<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Lifestyle changes for treating psoriasis - Ko, SH - 2019 | Cochrane Library</title> <meta content="Lifestyle changes for treating psoriasis - Ko, SH - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011972.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Lifestyle changes for treating psoriasis - Ko, SH - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011972.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011972.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Lifestyle changes for treating psoriasis" name="citation_title"/> <meta content="Shu‐Hua Ko" name="citation_author"/> <meta content="Wei‐Gong Memorial Hospital" name="citation_author_institution"/> <meta content="Ching‐Chi Chi" name="citation_author"/> <meta content="chingchi@cgmh.org.tw" name="citation_author_email"/> <meta content="Mei‐Ling Yeh" name="citation_author"/> <meta content="National Taipei University of Nursing and Health Sciences" name="citation_author_institution"/> <meta content="Shu‐Hui Wang" name="citation_author"/> <meta content="Far Eastern Memorial Hospital" name="citation_author_institution"/> <meta content="Yu‐Shiun Tsai" name="citation_author"/> <meta content="Chang Gung Memorial Hospital, Chiayi" name="citation_author_institution"/> <meta content="Mei‐Ya Hsu" name="citation_author"/> <meta content="Chang Gung Memorial Hospital, Chiayi" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD011972.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/07/16" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011972.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011972.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011972.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Life Style; *Quality of Life; Chronic Disease; Exercise [*physiology]; Obesity [complications, prevention &amp; control]; Pruritus [prevention &amp; control, therapy]; Psoriasis [prevention &amp; control, *therapy]; Randomized Controlled Trials as Topic; Walking" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011972.pub2&amp;doi=10.1002/14651858.CD011972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="dLyXbLct";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011972\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011972\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011972\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011972\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","zh_HANT","ru","ms","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011972.pub2",title:"Lifestyle changes for treating psoriasis",firstPublishedDate:"Jul 16, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Skin Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=dLyXbLct&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011972.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011972.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011972.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011972.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011972.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011972.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011972.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011972.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011972.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011972.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>11768 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011972.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/full#CD011972-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/full#CD011972-sec-0129"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/full#CD011972-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/full#CD011972-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/full#CD011972-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/full#CD011972-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/full#CD011972-sec-0070"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/full#CD011972-sec-0118"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/appendices#CD011972-sec-0137"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/table_n/CD011972StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/table_n/CD011972StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Lifestyle changes for treating psoriasis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/information#CD011972-cr-0002">Shu‐Hua Ko</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/information#CD011972-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Ching‐Chi Chi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/information#CD011972-cr-0004">Mei‐Ling Yeh</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/information#CD011972-cr-0005">Shu‐Hui Wang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/information#CD011972-cr-0006">Yu‐Shiun Tsai</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011972.pub2/information#CD011972-cr-0007">Mei‐Ya Hsu</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/information/en#CD011972-sec-0151">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 16 July 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011972.pub2">https://doi.org/10.1002/14651858.CD011972.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011972-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011972-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011972-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011972-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011972-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011972-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011972-abs-0001" lang="en"> <section id="CD011972-sec-0001"> <h3 class="title" id="CD011972-sec-0001">Background</h3> <p>Psoriasis is an inflammatory skin disease that presents with itching, red, scaling plaques; its worsening has been associated with obesity, drinking, smoking, lack of sleep, and a sedentary lifestyle. Lifestyle changes may improve psoriasis. </p> </section> <section id="CD011972-sec-0002"> <h3 class="title" id="CD011972-sec-0002">Objectives</h3> <p>To assess the effects of lifestyle changes for psoriasis, including weight reduction, alcohol abstinence, smoking cessation, dietary modification, exercise, and other lifestyle change interventions. </p> </section> <section id="CD011972-sec-0003"> <h3 class="title" id="CD011972-sec-0003">Search methods</h3> <p>We searched the following databases up to July 2018: the Cochrane Skin Specialised Register, CENTRAL, MEDLINE, Embase, and LILACS. We also searched the China National Knowledge Infrastructure, the Airiti Library, and five trials registers up to July 2018. We checked the references of included trials for further relevant trials, and we asked the authors of the included trials if they were aware of any relevant unpublished data. </p> </section> <section id="CD011972-sec-0004"> <h3 class="title" id="CD011972-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) of lifestyle changes (either alone or in combination) for treating psoriasis in people diagnosed by a healthcare professional. Treatment had to be given for at least 12 weeks. Eligible comparisons were no lifestyle changes or another active intervention. </p> </section> <section id="CD011972-sec-0005"> <h3 class="title" id="CD011972-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures expected by Cochrane. The primary outcome measures were 'Severity of psoriasis' and 'Adherence to the intervention'. Secondary outcomes were 'Quality of life', 'Time to relapse', and 'Reduction in comorbidities'. We used GRADE to assess the quality of the evidence for each outcome. </p> </section> <section id="CD011972-sec-0006"> <h3 class="title" id="CD011972-sec-0006">Main results</h3> <p>We included 10 RCTs with 1163 participants (mean age: 43 to 61 years; 656 men and 478 women were reported). Six trials examined the effects of dietary intervention (low‐calorie diet) in 499 obese participants (mean age: 44.3 to 61 years; where reported, 395 had moderate‐to‐severe psoriasis). One trial assessed a combined dietary intervention and exercise programme in 303 obese participants with moderate‐to‐severe psoriasis who had started a systemic therapy for psoriasis and had not achieved clearance after four weeks of continuous treatment (median age: 53 years). Another trial assessed a walking exercise and continuous health education in 200 participants (mean age: 43.1 years, severity not reported). Finally, two trials included education programmes promoting a healthy lifestyle in 161 participants (aged 18 to 78 years), with one trial on mild psoriasis and the other trial not reporting severity. </p> <p>Comparisons included information only; no intervention; medical therapy alone; and usual care (such as continuing healthy eating). </p> <p>All trials were conducted in hospitals and treated participants for between 12 weeks and three years. One trial did not report the treatment period. Seven trials measured the outcomes at the end of treatment and there was no additional follow‐up. In two trials, there was follow‐up after the treatment ended. Five trials had a high risk of performance bias, and four trials had a high risk of attrition bias. </p> <p>We found no trials assessing interventions for alcohol abstinence or smoking cessation. No trials assessed time to relapse. Only two trials assessed adverse events; in one trial these were caused by the add‐on therapy ciclosporin (given in both groups). The trial comparing two dietary interventions to a no‐treatment group observed no adverse events. </p> <p>The results presented in this abstract are based on trials of obese participants.</p> <p>Outcomes for dietary interventions versus usual care were measured 24 weeks to six months from baseline. Compared to usual care, dietary intervention (strict caloric restriction) may lead to 75% or greater improvement from baseline in the Psoriasis Area and Severity Index (PASI 75) (risk ratio (RR) 1.66, 95% confidence interval (CI) 1.07 to 2.58; 2 trials, 323 participants; low‐quality evidence). Adherence to the intervention may be greater with the dietary intervention than usual care, but the 95% CI indicates that the dietary intervention might also make little or no difference (RR 1.26, 95% CI 0.76 to 2.09; 2 trials, 105 participants; low‐quality evidence). Dietary intervention probably achieves a greater improvement in dermatology quality‐of‐life index (DLQI) score compared to usual care (MD −12.20, 95% CI −13.92 to −10.48; 1 trial, 36 participants; moderate‐quality evidence), and probably reduces the BMI compared to usual care (MD −4.65, 95% CI −5.93 to −3.36; 2 trials, 78 participants; moderate‐quality evidence). </p> <p>Outcomes for dietary interventions plus exercise programme were measured 16 weeks from baseline and are based on one trial (303 participants). Compared to information only (on reducing weight to improve psoriasis), combined dietary intervention and exercise programme (dietetic plan and physical activities) probably improves psoriasis severity, but the 95% CI indicates that the intervention might make little or no difference (PASI 75: RR 1.28, 95% CI 0.83 to 1.98). This combined intervention probably results in a greater reduction in BMI (median change −1.10 kg/m², P = 0.002), but there is probably no difference in adherence (RR 0.95, 95% CI 0.89 to 1.01; 137/151 and 145/152 participants adhered in the treatment and control group, respectively). There were no data on quality of life. These outcomes are based on moderate‐quality evidence. </p> </section> <section id="CD011972-sec-0007"> <h3 class="title" id="CD011972-sec-0007">Authors' conclusions</h3> <p>Dietary intervention may reduce the severity of psoriasis (low‐quality evidence) and probably improves quality of life and reduces BMI (moderate‐quality evidence) in obese people when compared with usual care, while combined dietary intervention and exercise programme probably improves psoriasis severity and BMI when compared with information only (moderate‐quality evidence). None of the trials measured quality of life. </p> <p>We did not detect a clear difference in treatment adherence between those in the combined dietary intervention and exercise programme group and those given information only (moderate‐quality evidence). Adherence may be improved through dietary intervention compared with usual care (low‐quality evidence). Participants generally adhered well to the lifestyle interventions assessed in the review. </p> <p>No trials assessed the time to relapse. Trial limitations included unblinded participants and high dropout rate. </p> <p>Future trials should reduce dropouts and include comprehensive outcome measures; they should examine whether dietary intervention with or without an exercise programme is effective in non‐obese people with psoriasis, whether an additional exercise programme is more effective than dietary intervention alone, whether the time to relapse prolongs in people who receive dietary intervention with or without exercise programme, and whether smoking cessation and alcohol abstinence are effective in treating psoriasis. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011972-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011972-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011972-abs-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011972-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011972-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011972-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011972-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011972-abs-0009">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011972-abs-0007">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD011972-abs-0008">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011972-abs-0005" lang="en"> <h3>Lifestyle changes for treating psoriasis</h3> <p><b>Review question</b> </p> <p>We wanted to see whether lifestyle changes (e.g. changing diet, exercising, and avoiding smoking and drinking alcohol), alone or combined, were useful in treating psoriasis when compared to no such changes or another psoriasis treatment. </p> <p><b>Background</b> </p> <p>Psoriasis is a long‐lasting, inflammatory skin disease; it causes thick, red, itching, and scaling patches. Obesity, drinking, smoking, and an inactive lifestyle can worsen psoriasis. We intended to find out if lifestyle changes can improve psoriasis severity and quality of life, and reduce comorbidities (other conditions occurring alongside a primary condition). </p> <p><b>Trial characteristics</b> </p> <p>We included 10 trials, with 1163 participants, which assessed the effects of low‐calorie diet alone; low‐calorie diet combined with an exercise programme; a combination of walking exercise and continuous health education; and educational instructions to promote a healthy lifestyle (diet, smoking, and alcohol abstinence). We examined the research evidence up to July 2018. </p> <p>Non‐profit organisations funded four trials, one trial received funding for the education programme from pharmaceutical companies, and the other five trials had no funding or did not report the funding source. All participants were aged at least 18 years (mean age: 43 to 61 years). Where reported, the trials included 656 men and 478 women; all were set in a hospital. In four trials, the participants were limited to people with moderate‐to‐severe psoriasis. One trial included participants who had initially been treated with oral medicines for moderate‐to‐severe psoriasis but whose psoriasis had not cleared after four weeks. In four trials, all severities of psoriasis were eligible, but these trials either did not report the participants’ psoriasis severity or only provided average severity scores. One trial included participants with mild psoriasis. Trials compared lifestyle change interventions with usual care (including to continue healthy eating), information only, no treatment, or medical treatment alone. Treatment was given for between 12 weeks to three years. </p> <p><b>Key results</b> </p> <p>The following results are based on obese participants and compare lifestyle change interventions (low‐calorie diet) to usual care. A low‐calorie diet may reduce the severity of psoriasis (when assessed as the proportion of participants achieving at least 75% improvement from the start of treatment in the Psoriasis Area and Severity Index (PASI 75), a widely used tool for the measurement of psoriasis severity) (low‐quality evidence) and probably improves quality of life (moderate‐quality evidence). Participants on a low‐calorie diet may be more likely to stick to treatment (treatment adherence), but treatment effects vary so it is possible that it may make little or no difference (low‐quality evidence). A low‐calorie diet probably improves BMI (body mass index: a healthy weight calculator) (moderate‐quality evidence). The trials did not say how long they treated participants before they stopped dieting (time to relapse). </p> <p>The following results are based on obese participants and compare lifestyle change interventions (low‐calorie diet plus an exercise programme) to weight‐loss information aimed at improving psoriasis. A low‐calorie diet plus an exercise programme probably results in a greater reduction in the severity of psoriasis (based on PASI 75), but the effects of this treatment vary, so it is possible that it may make little or no difference. There is probably no difference in treatment adherence between the two groups; however, a low‐calorie diet plus exercise programme probably improves BMI reduction (all outcomes based on moderate‐quality evidence). Trials did not report quality of life or time to relapse. </p> <p>Only two trials in this review assessed side effects. In one trial side effects were caused by an additional therapy given to both groups of participants (they were not caused by the dietary treatment). The other trial, which compared two dietary treatments to no treatment, did not observe any side effects. Generally, participants complied with the assessed lifestyle changes successfully. </p> <p>We found no trials on alcohol abstinence or smoking cessation.</p> <p><b>Quality of the evidence</b> </p> <p>The quality of evidence was moderate to low for the outcomes 'Severity of psoriasis' and 'Adherence to the intervention' and moderate for 'Reduction in comorbidities: change in Body Mass Index (BMI)'. Quality of life, measured in only one of the two key comparisons, was based on moderate‐quality evidence. Trial limitations included participants knowing which treatment they were receiving and large number of participants withdrawing from trials. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011972-sec-0129" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011972-sec-0129"></div> <h3 class="title" id="CD011972-sec-0130">Implications for practice</h3> <section id="CD011972-sec-0130"> <p>The body of evidence regarding the effects of lifestyle changes for treating psoriasis is limited, with a number of key interventions not assessed by any included trial, such as alcohol abstinence or smoking cessation. Most trials reported our primary outcomes, but evidence quality was variable, ranging from very low to moderate. </p> <p>The evidence in our review demonstrates that compared with usual care, dietary intervention (strict caloric restriction) may reduce psoriasis severity in obese people (low‐quality evidence) and probably improves quality of life and reduces body‐mass index (BMI) (moderate‐quality evidence). </p> <p>When compared with information only, combined dietary intervention and exercise probably leads to a greater reduction in BMI, but with no difference in treatment adherence (moderate‐quality evidence). For this comparison, there were no data on quality of life. The combined treatment probably improves psoriasis severity (moderate‐quality evidence), but the 95% confidence interval indicates that the combined intervention may also make little or no difference. Similarly, treatment adherence may be greater with dietary intervention than usual care, but for the same reason it may also make little or no difference (low‐quality evidence). The lifestyle interventions assessed in the review were largely well‐adhered to by the participants. </p> </section> <h3 class="title" id="CD011972-sec-0131">Implications for research</h3> <section id="CD011972-sec-0131"> <section id="CD011972-sec-0132"> <h5 class="title">Interventions and comparators</h5> <p>More trials are needed to provide evidence for the following questions.</p> <p> <ul id="CD011972-list-0017"> <li> <p>Whether dietary intervention with or without an exercise programme versus usual care is effective in non‐obese people with psoriasis? </p> </li> <li> <p>Whether additive exercise programme is better than dietary intervention alone in treating psoriasis? </p> </li> <li> <p>What are the effects of different dietary interventions (for example, vegetarian diet versus ketogenic diet) in treating psoriasis? </p> </li> <li> <p>What are the effects of different exercise programmes (for example, walking and jogging) in treating psoriasis? The comparisons could be one exercise programme versus another or sedentary lifestyle. </p> </li> <li> <p>Whether the time to relapse prolongs in people who receive dietary intervention with or without exercise programme when compared to usual care? </p> </li> <li> <p>Whether other lifestyle changes (for example, strict smoking cessation, alcohol abstinence programme, coping with stress, and non‐sedentary lifestyle) are effective in treating psoriasis when compared to usual care? </p> </li> </ul> </p> </section> <section id="CD011972-sec-0133"> <h5 class="title">Participants</h5> <p>To date only one trial (<a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>), has examined the effects of dietary intervention in people with mild to moderate psoriasis. More trials including participants with mild psoriasis are warranted to confirm the benefits of dietary intervention with or without an exercise programme in this population. Moreover, inclusion of non‐obese people with psoriasis in future trials will answer whether dietary intervention with or without exercise programme is effective in this population with psoriasis. </p> </section> <section id="CD011972-sec-0134"> <h5 class="title">Outcomes</h5> <p>The length of follow‐up in future trials should be at least 24 weeks and may be extended to one year or longer to examine the outcome 'Time to relapse'. Future trials should report participants' severity of psoriasis and adherence and trial authors should consult the Cochrane Skin Core Outcomes Set Initiative (<a href="./references#CD011972-bbs2-0033" title="Cochrane Skin Core Outcome Set Initiative. cs‐cousin.org/ (accessed prior to 11 July 2019). ">CS‐COUSIN 2019</a>) to check for any core outcome measures. </p> <p>Loss to follow‐up exceeded 20% in three trials; future trials should routinely incorporate various measures to minimise dropouts. Where practical, trials should be double‐blinded to reduce performance and detection bias. </p> <p>In addition, the effects of lifestyle changes for treating other skin conditions, not just psoriasis, should be assessed. For example, obesity has been associated with an increased prevalence of atopic dermatitis (<a href="./references#CD011972-bbs2-0078" title="ZhangA , SilverbergJI . Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis. Journal of the American Academy of Dermatology2015;72(4):606‐16.e4. [PUBMED: 25773409] ">Zhang 2015</a>); therefore, the effects of weight reduction on the severity of atopic dermatitis should be examined. </p> </section> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011972-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011972-sec-0029"></div> <div class="table" id="CD011972-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Dietary intervention compared to usual care for treating psoriasis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dietary intervention compared to usual care for treating psoriasis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with psoriasis<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> dietary intervention<br/> <b>Comparison:</b> usual care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with usual care</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with dietary intervention</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Severity of psoriasis</b> </p> <p>PASI 75 (the proportion of participants achieving at least 75% improvement from baseline in the Psoriasis Area and Severity Index)<br/> Follow‐up: 24 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Trial population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.66<br/> (1.07 to 2.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>323<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>537 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>891 per 1000<br/> (575 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adherence to the intervention</b><br/> Follow‐up: 24 weeks to 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Trial population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.26<br/> (0.76 to 2.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>105<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>654 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>824 per 1000<br/> (497 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> <p>Change in DLQI (scale from 0 to 30; lower DLQI scores represent improvement in quality of life) </p> <p>Follow‐up: 6 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life assessed by change in DLQI was −2.2</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 12.20 lower<br/> (13.92 lower to 10.48 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to relapse</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in comorbidities</b> </p> <p>Change in BMI (lower BMI is beneficial)<br/> Follow‐up: 24 weeks to 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in comorbidities assessed by change in BMI was 0.1 kg/m²</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 4.65 kg/m² lower<br/> (5.93 lower to 3.36 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BMI:</b> body‐mass index; <b>CI:</b> confidence interval; <b>DLQI:</b> Dermatology Life Quality Index; <b>MD:</b> mean difference; <b>PASI:</b> Psoriasis Area and Severity Index; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by two levels due to a high risk of attrition bias or performance bias, and inconsistency.<br/> <sup>b</sup>Downgraded by one level due to a high risk of performance bias. </p> <p>None of the outcomes reported here were downgraded for imprecision as the optimal information size was met (<a href="./appendices#CD011972-sec-0148">Appendix 11</a>). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011972-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Dietary intervention and exercise programme compared to information only for treating psoriasis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dietary intervention and exercise programme compared to information only for treating psoriasis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with psoriasis<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> dietary intervention and exercise programme<br/> <b>Comparison:</b> information only </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with information only</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with dietary intervention and exercise programme</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Severity of psoriasis</b> </p> <p>PASI 75 (the proportion of participants achieving at least 75% improvement from baseline in the Psoriasis Area and Severity Index)<br/> Follow‐up: 16 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Trial population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.28<br/> (0.83 to 1.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>303<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>191 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>244 per 1000<br/> (158 to 378) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adherence to the intervention</b><br/> Follow‐up: 16 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Trial population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.95<br/> (0.89 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>303<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>954 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>906 per 1000<br/> (849 to 963) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to relapse</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in comorbidities</b> </p> <p>Change in BMI (lower BMI is beneficial)<br/> Follow‐up: 16 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Median change in BMI was 1.9 kg/m²</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Median 1.10 kg/m² lower</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>303<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The diet and exercise group had a significantly greater reduction in BMI (median 3.0, IQR 5.2) than the information only group (median 1.9, IQR 3.6; P = 0.002, Mann‐Whitney U test) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BMI:</b> body‐mass index; <b>CI:</b> confidence interval; <b>IQR:</b> interquartile range; <b>PASI:</b> Psoriasis Area and Severity Index; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by one level due to a high risk of attrition bias. </p> <p>None of the outcomes reported here were downgraded for imprecision as the optimal information size was met (<a href="./appendices#CD011972-sec-0148">Appendix 11</a>). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011972-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011972-sec-0030"></div> <section id="CD011972-sec-0031"> <h3 class="title" id="CD011972-sec-0031">Description of the condition</h3> <p>Psoriasis is a chronic inflammatory skin disease affecting about 2% of the population worldwide (<a href="./references#CD011972-bbs2-0062" title="ParisiR , SymmonsDP , GriffithsCE , AshcroftDM . Global epidemiology of psoriasis: a systematic review of incidence and prevalence. Journal of Investigative Dermatology2013;133(2):377‐85. [PUBMED: 23014338] ">Parisi 2013</a>). Psoriasis most frequently presents with red scaly plaques involving the scalp, trunk and extensor parts of the limbs (backs of elbows and front of knees; <a href="./references#CD011972-bbs2-0073" title="TreloarV . Integrative dermatology for psoriasis: facts and controversies. Clinics in Dermatology2010;28(1):93‐9. [PUBMED: 20082958] ">Treloar 2010</a>). About 50% of people with psoriasis have nail involvement that may deform their nails (<a href="./references#CD011972-bbs2-0034" title="DeVriesAC , BogaardsNA , HooftL , VelemaM , PaschM , LebwohlM , et al. Interventions for nail psoriasis. Cochrane Database of Systematic Reviews2013, Issue 1. [DOI: 10.1002/14651858.CD007633.pub2] ">De Vries 2013</a>). Psoriasis may also present with pustular lesions or with erythroderma, that is, extensive red lesions that involve the entire or almost entire skin (<a href="./references#CD011972-bbs2-0026" title="CampRD . Psoriasis. In: ChampionRH , BurtonJL , EblingEJG editor(s). Textbook of Dermatology. 5th Edition. Vol. 2, Oxford: Blackwell Scientific Publications, 1992:1391‐1457. ">Camp 1992</a>). Guttate psoriasis is a specific form that primarily occurs in children and young adults following a streptococcal sore throat or tonsillitis (<a href="./references#CD011972-bbs2-0061" title="OwenCM , ChalmersR , O'SullivanT , GriffithsCE . Antistreptococcal interventions for guttate and chronic plaque psoriasis. Cochrane Database of Systematic Reviews2000, Issue 2. [DOI: 10.1002/14651858.CD001976] ">Owen 2000</a>). The characteristic lesions are usually adequate for a diagnosis of psoriasis to be made, though a skin biopsy may sometimes be needed for confirmation when doubt arises (<a href="./references#CD011972-bbs2-0026" title="CampRD . Psoriasis. In: ChampionRH , BurtonJL , EblingEJG editor(s). Textbook of Dermatology. 5th Edition. Vol. 2, Oxford: Blackwell Scientific Publications, 1992:1391‐1457. ">Camp 1992</a>). The Psoriasis Area and Severity Index (PASI) score is a weighted scoring system of the severity of psoriasis that ranges from 0 to 72 and is calculated based on the proportion of involved skin, degree of erythema, scaling, and induration (<a href="./references#CD011972-bbs2-0039" title="FeldmanSR , KruegerGG . Psoriasis assessment tools in clinical trials. Annals of the Rheumatic Diseases2005;64(Suppl 2):ii65‐8; discussion ii69‐73. [PUBMED: 15708941] ">Feldman 2005</a>). Mild psoriasis is usually defined as a PASI score of under 10, while moderate to severe is defined as a PASI score of 10 or above (<a href="./references#CD011972-bbs2-0057" title="MrowietzU , KragballeK , ReichK , SpulsP , GriffithsCE , NastA , et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Archives of Dermatological Research2011;303(1):1‐10. [PUBMED: 20857129] ">Mrowietz 2011</a>; <a href="./references#CD011972-bbs2-0074" title="TsaiTF , LeeCH , HuangYH , ChiCC , ChangYT , WongTW , et al. Taiwanese Dermatological Association consensus statement on management of psoriasis. Dermatologica Sinica2017;35(2):66‐77. [DOI: 10.1016/j.dsi.2017.01.002] ">Tsai 2017</a>). Psoriasis has a huge impact on quality of life (<a href="./references#CD011972-bbs2-0053" title="KoW‐C , TsaiT‐F , TangC‐H . Health state utility, willingness to pay, and quality of life among Taiwanese patients with psoriasis. Dermatologica Sinica2016;34(4):185‐91. [EMBASE: 20160830045] ">Ko 2016</a>), especially of people with skin lesions involving the hands and face (<a href="./references#CD011972-bbs2-0077" title="YangHJ , YangKC . Impact of psoriasis on quality of life in Taiwan. Dermatologica Sinica2015;33(3):146‐50. [DOI: 10.1016/j.dsi.2015.02.001] ">Yang 2015</a>). Psoriasis places a heavy economic burden on healthcare systems (<a href="./references#CD011972-bbs2-0030" title="ChiCC , WangSH . Efficacy and cost‐efficacy of biologic therapies for moderate to severe psoriasis: a meta‐analysis and cost‐efficacy analysis using the intention‐to‐treat principle. BioMed Research International2014; Vol. 2014:862851. [DOI: 10.1155/2014/862851; PUBMED: 24605338] ">Chi 2014</a>). For example, the annual costs of adalimumab treatment per patient is around GBP 10,000 in the UK (<a href="./references#CD011972-bbs2-0060" title="National Institute for Health and Care Excellence. Adalimumab for the treatment of adults with psoriasis. Technology appraisal guidance [TA146] 2008. www.nice.org.uk/guidance/ta146. London, (accessed 17 October 2017). ">NICE 2008</a>). </p> <p>The pathogenesis of psoriasis involves the activation of T lymphocytes (a type of white blood cell) with resultant production of proinflammatory cytokines (a category of small proteins that carry signals), for example, tumour necrosis factor (TNF) and interleukin (IL)‐17, leading to inflammation and proliferation of the skin (<a href="./references#CD011972-bbs2-0059" title="NestleFO , KaplanDH , BarkerJ . Psoriasis. New England Journal of Medicine2009;361(5):496‐509. [PUBMED: 19641206] ">Nestle 2009</a>). Chronic inflammation is considered the link between psoriasis and associated comorbidities (i.e. other diseases co‐occurring with psoriasis), such as metabolic syndrome, cardiovascular disease, stroke, renal diseases, and uveitis (<a href="./references#CD011972-bbs2-0076" title="WangSH , ChiCC , HuS . Cost‐efficacy of biologic therapies for moderate to severe psoriasis from the perspective of the Taiwanese healthcare system. International Journal of Dermatology2014;53(9):1151‐6. [PUBMED: 24738910] ">Wang 2014</a>; <a href="./references#CD011972-bbs2-0031" title="ChiCC , WangJ , ChenYF , WangSH , ChenFL , TungTH . Risk of incident chronic kidney disease and end‐stage renal disease in patients with psoriasis: a nationwide population‐based cohort study. Journal of Dermatological Science2015;78(3):232‐8. [DOI: 10.1016/j.jdermsci.2015.03.012; PUBMED: 25862150] ">Chi 2015</a>; <a href="./references#CD011972-bbs2-0032" title="ChiCC , TungTH , WangJ , LinYS , ChenYF , HsuTK , et al. Risk of uveitis among people with psoriasis: a nationwide cohort study. JAMA Ophthalmology2017;135(5):415‐22. [PUBMED: 28418500] ">Chi 2017</a>). Psoriasis has also been associated with hyperlipidaemia, which is a broad term describing abnormal elevation of blood lipids, including hypercholesterolaemia and hypertriglyceridaemia that refers to abnormal elevation of the blood levels of cholesterol and triglyceride, respectively (<a href="./references#CD011972-bbs2-0055" title="MaC , HarskampCT , ArmstrongEJ , ArmstrongAW . The association between psoriasis and dyslipidaemia: a systematic review. British Journal of Dermatology2013;168(3):486‐95. [PUBMED: 23106411] ">Ma 2013</a>; <a href="./references#CD011972-bbs2-0074" title="TsaiTF , LeeCH , HuangYH , ChiCC , ChangYT , WongTW , et al. Taiwanese Dermatological Association consensus statement on management of psoriasis. Dermatologica Sinica2017;35(2):66‐77. [DOI: 10.1016/j.dsi.2017.01.002] ">Tsai 2017</a>). </p> <p>Previous epidemiological trials have found that compared to the general population, people with mild psoriasis had a 1.08‐fold to 1.29‐fold risk of incident (i.e. newly developed) myocardial infarction while those with severe psoriasis had a 1.36‐fold to 3.10‐fold risk of incident myocardial infarction (<a href="./references#CD011972-bbs2-0044" title="GelfandJM , NeimannAL , ShinDB , WangX , MargolisDJ , TroxelAB . Risk of myocardial infarction in patients with psoriasis. JAMA2006;296(14):1735‐41. [PUBMED: 17032986] ">Gelfand 2006</a>). Also, people with mild psoriasis had an 1.06‐fold risk of incident stroke while those with severe psoriasis had an 1.43‐fold risk of incident stroke compared to the general population (<a href="./references#CD011972-bbs2-0045" title="GelfandJM , DommaschED , ShinDB , AzfarRS , KurdSK , WangX , et al. The risk of stroke in patients with psoriasis. Journal of Investigative Dermatology2009;129(10):2411‐8. [PUBMED: 19458634] ">Gelfand 2009</a>). However, the causality between these risks and psoriasis is not clear. Inflammation may play a role comorbid cardiovascular diseases; however, other factors might also play a role. For example, genetic trials have found that people with psoriasis frequently carry certain common genes predisposing to increased risk for hyperlipidaemia, hypertension, and cardiovascular disease (<a href="./references#CD011972-bbs2-0054" title="LuY , ChenH , NikamoP , Qi LowH , HelmsC , SeielstadM , et al. Association of cardiovascular and metabolic disease genes with psoriasis. Journal of Investigative Dermatology2013; Vol. 133, issue 3:836‐9. [PUBMED: 23190900] ">Lu 2013</a>). </p> <p>Obesity has been associated with the development of psoriasis and psoriasis of increased severity (<a href="./references#CD011972-bbs2-0035" title="DebbanehM , MillsopJW , BhatiaBK , KooJ , LiaoW . Diet and psoriasis, part I: Impact of weight loss interventions. Journal of the American Academy of Dermatology2014;71(1):133‐40. [PUBMED: 24709272] ">Debbaneh 2014</a>). It has been proposed that the fat tissue acts like an endocrine organ (i.e. an organ that directly secretes hormones into the blood stream) and secretes proteins, such as adiponectin and leptin, which are involved in inflammation, altered glucose metabolism, and alterations in the inner lining of blood vessels (<a href="./references#CD011972-bbs2-0047" title="GerdesS , Rostami‐YazdiM , MrowietzU . Adipokines and psoriasis. Experimental Dermatology2011;20(2):81‐7. [PUBMED: 21255085] ">Gerdes 2011</a>). </p> <p>In addition to obesity, unhealthy lifestyles, such as excessive alcohol consumption, smoking, and a sedentary lifestyle, have been associated with onset and worsening of psoriasis (<a href="./references#CD011972-bbs2-0046" title="GerdesS , ZahlVA , WeichenthalM , MrowietzU . Smoking and alcohol intake in severely affected patients with psoriasis in Germany. Dermatology2010;220(1):38‐43. [PUBMED: 19996578] ">Gerdes 2010</a>; <a href="./references#CD011972-bbs2-0043" title="FrankelHC , HanJ , LiT , QureshiAA . The association between physical activity and the risk of incident psoriasis. Archives of Dermatology2012;148(8):918‐24. [PUBMED: 22911187] ">Frankel 2012</a>; <a href="./references#CD011972-bbs2-0017" title="KeyworthC , NelsonPA , BundyC , GriffithsCE , CordingleyL . Does health message framing affect behavioural intentions in patients with psoriasis? An experimental study. British Journal of Dermatology2014;171(6):e143‐4. [CENTRAL: CN‐01088032] ">Keyworth 2014</a>). Stress (<a href="./references#CD011972-bbs2-0058" title="NaldiL , ChatenoudL , LinderD , Belloni FortinaA , PesericoA , VirgiliAR , et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case‐control study. Journal of Investigative Dermatology2005;125(1):61‐7. [PUBMED: 15982303] ">Naldi 2005</a>; <a href="./references#CD011972-bbs2-0023" title="AltunayI , DonerN , MercanS , DemirciGT . Stress coping mechanisms in smoking psoriatics. Dermatologica Sinica2013;31(3):130‐3. [DOI: 10.1016/j.dsi.2013.02.001] ">Altunay 2013</a>), and lack of sleep (<a href="./references#CD011972-bbs2-0073" title="TreloarV . Integrative dermatology for psoriasis: facts and controversies. Clinics in Dermatology2010;28(1):93‐9. [PUBMED: 20082958] ">Treloar 2010</a>), are also associated with worsening of psoriasis. The mechanism underlying the link between stress and exacerbation of psoriasis is unclear, but may involve the promotion of neurogenic inflammation, change in the neuroendocrine system, and redirecting leukocytes to the skin (<a href="./references#CD011972-bbs2-0051" title="HunterHJ , GriffithsCE , KleynCE . Does psychosocial stress play a role in the exacerbation of psoriasis?. British Journal of Dermatology2013;169(5):965‐74. [PUBMED: 23796214] ">Hunter 2013</a>; <a href="./references#CD011972-bbs2-0066" title="RyanC , KormanNJ , GelfandJM , LimHW , ElmetsCA , FeldmanSR , et al. Research gaps in psoriasis: opportunities for future studies. Journal of the American Academy of Dermatology2014;70(1):146‐67. [PUBMED: 24126079] ">Ryan 2014</a>). </p> </section> <section id="CD011972-sec-0032"> <h3 class="title" id="CD011972-sec-0032">Description of the intervention</h3> <p>Psoriasis usually follows a relapsing‐remitting course, but may evolve into persistent severe disease (<a href="./references#CD011972-bbs2-0073" title="TreloarV . Integrative dermatology for psoriasis: facts and controversies. Clinics in Dermatology2010;28(1):93‐9. [PUBMED: 20082958] ">Treloar 2010</a>); there is no cure for psoriasis (<a href="./references#CD011972-bbs2-0066" title="RyanC , KormanNJ , GelfandJM , LimHW , ElmetsCA , FeldmanSR , et al. Research gaps in psoriasis: opportunities for future studies. Journal of the American Academy of Dermatology2014;70(1):146‐67. [PUBMED: 24126079] ">Ryan 2014</a>). The current available medical interventions include topical drugs (<a href="./references#CD011972-bbs2-0056" title="MasonAR , MasonJ , CorkM , DooleyG , HancockH . Topical treatments for chronic plaque psoriasis. Cochrane Database of Systematic Reviews2013, Issue 3. [DOI: 10.1002/14651858.CD005028.pub3] ">Mason 2013</a>), phototherapy (<a href="./references#CD011972-bbs2-0027" title="ChenX , YangM , ChengY , LiuGJ , ZhangM . Narrow‐band ultraviolet B phototherapy versus broad‐band ultraviolet B or psoralen‐ultraviolet A photochemotherapy for psoriasis. Cochrane Database of Systematic Reviews2013, Issue 10. [DOI: 10.1002/14651858.CD009481.pub2] ">Chen 2013b</a>), and systemic drugs (<a href="./references#CD011972-bbs2-0076" title="WangSH , ChiCC , HuS . Cost‐efficacy of biologic therapies for moderate to severe psoriasis from the perspective of the Taiwanese healthcare system. International Journal of Dermatology2014;53(9):1151‐6. [PUBMED: 24738910] ">Wang 2014</a>). The clinical decision for using these interventions either alone or in combination is made by physicians after considering the evidence for efficacy and safety, disease severity, and the person's preferences and circumstances (<a href="./references#CD011972-bbs2-0029" title="ChiCC . Evidence‐based dermatology. Dermatologica Sinica2013;31(1):2‐6. [DOI: 10.1016/j.dsi.2012.06.002] ">Chi 2013</a>). </p> <p>Psoriasis is associated with metabolic and cardiovascular comorbidities that lifestyle changes, such as weight reduction, may modify (<a href="./references#CD011972-bbs2-0031" title="ChiCC , WangJ , ChenYF , WangSH , ChenFL , TungTH . Risk of incident chronic kidney disease and end‐stage renal disease in patients with psoriasis: a nationwide population‐based cohort study. Journal of Dermatological Science2015;78(3):232‐8. [DOI: 10.1016/j.jdermsci.2015.03.012; PUBMED: 25862150] ">Chi 2015</a>). The lifestyle change interventions that are potentially effective in treating psoriasis include diet, exercise, weight reduction, smoking cessation, and alcohol abstinence. </p> </section> <section id="CD011972-sec-0033"> <h3 class="title" id="CD011972-sec-0033">How the intervention might work</h3> <p>The potential mechanism of lifestyle interventions in treating psoriasis is shown in <a href="#CD011972-tbl-0003">Table 1</a>. </p> <div class="table" id="CD011972-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Potential mechanism of lifestyle change interventions in treating psoriasis</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Lifestyle change intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Potential mechanism in treating psoriasis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weight reduction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reduction of the amounts of adipose tissue that causes inflammation</p> <p>Decrease in the volume of drug distribution</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Alcohol abstinence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reduction of inflammation associated with alcohol consumption</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Smoking cessation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reduction of the production of free radicals induced by smoking</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement of the body composition</p> <p>Reduction of inflammation</p> </td> </tr> </tbody> </table> </div> <p>Adipose (fat) tissue in obese people with psoriasis produces inflammatory adipokines (bioactive products) and propagates inflammation, which plays a major role in both psoriasis and its associated comorbidities (<a href="./references#CD011972-bbs2-0047" title="GerdesS , Rostami‐YazdiM , MrowietzU . Adipokines and psoriasis. Experimental Dermatology2011;20(2):81‐7. [PUBMED: 21255085] ">Gerdes 2011</a>). The excessive adipose tissue in obesity may also increase the volume of drug distribution and diminish the response to medical treatments (<a href="./references#CD011972-bbs2-0072" title="ToussirotE , AubinF , DumoulinG . Relationships between adipose tissue and psoriasis, with or without arthritis. Frontiers in Immunology2014;5:368. [PUBMED: 25161652] ">Toussirot 2014</a>). Two biological therapies, infliximab and ustekinumab, adopt weight‐adjusted regimens to overcome the decrease in clinical response in obese people (<a href="./references#CD011972-bbs2-0030" title="ChiCC , WangSH . Efficacy and cost‐efficacy of biologic therapies for moderate to severe psoriasis: a meta‐analysis and cost‐efficacy analysis using the intention‐to‐treat principle. BioMed Research International2014; Vol. 2014:862851. [DOI: 10.1155/2014/862851; PUBMED: 24605338] ">Chi 2014</a>). Weight reduction decreases the amounts of adipose tissue, and therefore could reduce inflammation and improve the severity of psoriasis and the response to medical treatments (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>). In addition, weight reduction may lead to increased exercise tolerance (<a href="./references#CD011972-bbs2-0042" title="FossML , LampmanRM , SchteingartDE . Extremely obese patients: improvements in exercise tolerance with physical training and weight loss. Archives of Physical Medicine and Rehabilitation1980;61(3):119‐24. [PUBMED: 7369849] ">Foss 1980</a>), and a positive psychological impact (<a href="./references#CD011972-bbs2-0038" title="EssayliJH , MurakamiJM , WilsonRE , LatnerJD . The impact of weight labels on body image, internalized weight stigma, affect, perceived health, and intended weight loss behaviors in normal‐weight and overweight college women. American Journal of Health Promotion2017;31(6):484‐90. [PUBMED: 27553058] ">Essayli 2017</a>). </p> <p>Excessive alcohol consumption and smoking have been associated with psoriasis of increased severity (<a href="./references#CD011972-bbs2-0046" title="GerdesS , ZahlVA , WeichenthalM , MrowietzU . Smoking and alcohol intake in severely affected patients with psoriasis in Germany. Dermatology2010;220(1):38‐43. [PUBMED: 19996578] ">Gerdes 2010</a>). TNF‐α plays a major role in inflammation, which is a key feature in psoriasis (<a href="./references#CD011972-bbs2-0069" title="SerwinAB , SokolowskaM , ChodynickaB . Tumour necrosis factor alpha (TNF‐alpha)‐converting enzyme (TACE) and soluble TNF‐alpha receptor type 1 in psoriasis patients treated with narrowband ultraviolet B. Photodermatology, Photoimmunology &amp; Photomedicine2007;23(4):130‐4. [PUBMED: 17598866] ">Serwin 2007</a>). Excessive alcohol consumption increases the expression of TNF‐α‐converting enzyme (TACE) and plasma levels of tumour necrosis factor‐α receptor (sTNF‐α‐R1; <a href="./references#CD011972-bbs2-0070" title="SerwinAB , SokolowskaM , DylejkoE , ChodynickaB . Tumour necrosis factor (TNF‐alpha) alpha converting enzyme and soluble TNF‐alpha receptor type 1 in psoriasis patients in relation to the chronic alcohol consumption. Journal of the European Academy of Dermatology and Venereology: JEADV2008;22(6):712‐7. [PUBMED: 18312327] ">Serwin 2008</a>). Smoking induces the production of free radicals that trigger inflammation and thus may promote the development of psoriasis (<a href="./references#CD011972-bbs2-0024" title="ArmstrongAW , HarskampCT , DhillonJS , ArmstrongEJ . Psoriasis and smoking: a systematic review and meta‐analysis. British Journal of Dermatology2014;170(2):304‐14. [PUBMED: 24117435] ">Armstrong 2014</a>). Furthermore, smoking may increase the already increased risk of comorbid cardiovascular disease in people with psoriasis (<a href="./references#CD011972-bbs2-0024" title="ArmstrongAW , HarskampCT , DhillonJS , ArmstrongEJ . Psoriasis and smoking: a systematic review and meta‐analysis. British Journal of Dermatology2014;170(2):304‐14. [PUBMED: 24117435] ">Armstrong 2014</a>). Thus, alcohol abstinence and smoking cessation may help reduce inflammation and the severity of psoriasis (<a href="./references#CD011972-bbs2-0073" title="TreloarV . Integrative dermatology for psoriasis: facts and controversies. Clinics in Dermatology2010;28(1):93‐9. [PUBMED: 20082958] ">Treloar 2010</a>). </p> <p>Previous trials have found that exercise improves body composition (i.e. lowering of the percentage of body fat), reduces stress, and lessens chronic inflammation and the levels of pro‐inflammatory cytokines (small proteins released by cells that promote inflammation; <a href="./references#CD011972-bbs2-0073" title="TreloarV . Integrative dermatology for psoriasis: facts and controversies. Clinics in Dermatology2010;28(1):93‐9. [PUBMED: 20082958] ">Treloar 2010</a>; <a href="./references#CD011972-bbs2-0043" title="FrankelHC , HanJ , LiT , QureshiAA . The association between physical activity and the risk of incident psoriasis. Archives of Dermatology2012;148(8):918‐24. [PUBMED: 22911187] ">Frankel 2012</a>). Therefore, exercise may improve both the severity and comorbidities of psoriasis (<a href="./references#CD011972-bbs2-0073" title="TreloarV . Integrative dermatology for psoriasis: facts and controversies. Clinics in Dermatology2010;28(1):93‐9. [PUBMED: 20082958] ">Treloar 2010</a>). </p> </section> <section id="CD011972-sec-0034"> <h3 class="title" id="CD011972-sec-0034">Why it is important to do this review</h3> <p>Although there is a large body of evidence on the associations between unhealthy lifestyles and worsening of psoriasis, it is unclear if lifestyle changes can effectively reduce the severity of psoriasis or prolong the remission of psoriasis (<a href="./references#CD011972-bbs2-0066" title="RyanC , KormanNJ , GelfandJM , LimHW , ElmetsCA , FeldmanSR , et al. Research gaps in psoriasis: opportunities for future studies. Journal of the American Academy of Dermatology2014;70(1):146‐67. [PUBMED: 24126079] ">Ryan 2014</a>). We conducted a systematic review to evaluate the evidence of the effects of lifestyle changes in treating psoriasis. </p> <p>The plans for this review were published as a protocol 'Lifestyle changes for treating psoriasis' (<a href="./references#CD011972-bbs2-0079" title="ChiCC , KoSH , YehML , WangSH , TsaiYS , HsuMY . Lifestyle changes for treating psoriasis. Cochrane Database of Systematic Reviews2015, Issue 11. [DOI: 10.1002/14651858.CD011972] ">Chi 2015b</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011972-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011972-sec-0035"></div> <p>To assess the effects of lifestyle changes for psoriasis, including weight reduction, alcohol abstinence, smoking cessation, dietary modification, exercise, and other lifestyle change interventions. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011972-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011972-sec-0036"></div> <section id="CD011972-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011972-sec-0038"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) that assessed the effects of lifestyle changes for treating psoriasis. Interventions had to be given for at least 12 weeks, which is the current gold standard, short‐term endpoint of clinical trials on interventions for treating psoriasis (<a href="./references#CD011972-bbs2-0066" title="RyanC , KormanNJ , GelfandJM , LimHW , ElmetsCA , FeldmanSR , et al. Research gaps in psoriasis: opportunities for future studies. Journal of the American Academy of Dermatology2014;70(1):146‐67. [PUBMED: 24126079] ">Ryan 2014</a>). </p> </section> <section id="CD011972-sec-0039"> <h4 class="title">Types of participants</h4> <p>People with psoriasis diagnosed by a healthcare professional. We did not impose any limitations on the severity of psoriasis or the age of the participants. </p> </section> <section id="CD011972-sec-0040"> <h4 class="title">Types of interventions</h4> <p>We included all lifestyle change interventions, including the following:</p> <p> <ul id="CD011972-list-0001"> <li> <p>weight reduction;</p> </li> <li> <p>alcohol abstinence;</p> </li> <li> <p>smoking cessation;</p> </li> <li> <p>dietary modification;</p> </li> <li> <p>exercise; and</p> </li> <li> <p>other lifestyle change interventions.</p> </li> </ul> </p> <p>We compared all of the listed lifestyle change interventions either alone or in combination against no lifestyle changes or another active intervention. </p> </section> <section id="CD011972-sec-0041"> <h4 class="title">Types of outcome measures</h4> <p>Except for the outcome 'time to relapse', we assessed the following outcomes at week 12, week 24, and year 1. If there were no data at these time points, we assessed data at other available time points. </p> <section id="CD011972-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD011972-list-0002"> <li> <p>Severity of psoriasis: the proportion of participants achieving at least 75% improvement from baseline in the Psoriasis Area and Severity Index (PASI 75). A European consensus proposed PASI 75 as a treatment goal for psoriasis (<a href="./references#CD011972-bbs2-0057" title="MrowietzU , KragballeK , ReichK , SpulsP , GriffithsCE , NastA , et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Archives of Dermatological Research2011;303(1):1‐10. [PUBMED: 20857129] ">Mrowietz 2011</a>). We also reported the proportion of participants achieving at least 50%, 90%, or 100% improvement from baseline in PASI (i.e. PASI 50, PASI 90, and PASI 100, respectively) when relevant data were available. If none of these were available, we would use other validated assessment tools for psoriasis, including Body Surface Area (BSA), Physician Global Assessment (PGA), Lattice System Physician's Global Assessment (LS‐PGA), Self‐Administered Psoriasis Area Severity Index (SAPASI), Salford Psoriasis Index (SPI), Copenhagen Psoriasis Severity Index (CoPSI), and other validated assessment tools for psoriasis (<a href="./references#CD011972-bbs2-0064" title="PuzenatE , BronsardV , PreyS , GourraudPA , AractingiS , BagotM , et al. What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature. Journal of the European Academy of Dermatology and Venereology: JEADV2010;24 Suppl 2:10‐6. [PUBMED: 20443995] ">Puzenat 2010</a>). </p> </li> <li> <p>Adherence to the intervention (i.e. following the assigned intervention): the proportion of participants adhering to their allocated treatment. </p> </li> </ul> </p> </section> <section id="CD011972-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD011972-list-0003"> <li> <p>Quality of life: as measured by validated tools, including Dermatology Life Quality Index (DLQI), 36‐item Short Form (SF‐36), Skindex 29, Skindex 17, Dermatology Quality of life Scale (DQOLS), Psoriasis Disability Index (PDI), Impact of Psoriasis Questionnaire (IPSO), Psoriasis Index of Quality of Life (PSORIQOL), and other validated quality‐of‐life assessment tools for psoriasis (<a href="./references#CD011972-bbs2-0025" title="BronsardV , PaulC , PreyS , PuzenatE , GourraudPA , AractingiS , et al. What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. Journal of the European Academy of Dermatology and Venereology: JEADV2010;24 Suppl 2:17‐22. [PUBMED: 20443996] ">Bronsard 2010</a>). Regarding the DLQI, we considered a DLQI score change of at least 5 as a minimally important difference (<a href="./references#CD011972-bbs2-0052" title="KhiljiFA , GonzalezM , FinlayAY . Clinical meaning of change in Dermatology Life Quality Index scores. British Journal of Dermatology2001;147(Suppl 62):25‐54. ">Khilji 2001</a>). </p> </li> <li> <p>Time to relapse</p> </li> <li> <p>Reduction in comorbidities (i.e. diseases associated with psoriasis, for example, reduction in obesity, hypertension, diabetes mellitus, and metabolic syndrome). </p> </li> </ul> </p> </section> </section> </section> <section id="CD011972-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <p>We aimed to identify all relevant randomised controlled trials (RCTs) regardless of language or publication status (published, unpublished, in press, or in progress). </p> <section id="CD011972-sec-0045"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Skin Information Specialist searched the following databases up to 17 July 2018 using strategies based on the draft strategy for MEDLINE in our published protocol (<a href="./references#CD011972-bbs2-0079" title="ChiCC , KoSH , YehML , WangSH , TsaiYS , HsuMY . Lifestyle changes for treating psoriasis. Cochrane Database of Systematic Reviews2015, Issue 11. [DOI: 10.1002/14651858.CD011972] ">Chi 2015b</a>): </p> <p> <ul id="CD011972-list-0004"> <li> <p>the Cochrane Skin Group's Specialised Registers using the search strategy in <a href="./appendices#CD011972-sec-0138">Appendix 1</a>; </p> </li> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL; 2018, Issue 6) in the Cochrane Library using the strategy in <a href="./appendices#CD011972-sec-0139">Appendix 2</a>; </p> </li> <li> <p>MEDLINE via Ovid (from 1946 to 17 July 2018) using the strategy in <a href="./appendices#CD011972-sec-0140">Appendix 3</a>; </p> </li> <li> <p>Embase via Ovid (from 1974 to 17 July 2018) using the strategy in <a href="./appendices#CD011972-sec-0141">Appendix 4</a>; and </p> </li> <li> <p>LILACS (Latin American and Caribbean Health Science Information database; from 1982 to 17 July 2018) using the strategy in <a href="./appendices#CD011972-sec-0142">Appendix 5</a>. </p> </li> </ul> </p> <p>Two review authors (CC and YT) searched the following databases up to 6 August 2018:</p> <p> <ul id="CD011972-list-0005"> <li> <p>China National Knowledge Infrastructure (CNKI; from 1994) using the strategy in <a href="./appendices#CD011972-sec-0143">Appendix 6</a>; and </p> </li> <li> <p>Airiti Library (publications and theses from Taiwan; from 1991) using the strategy in <a href="./appendices#CD011972-sec-0144">Appendix 7</a>. </p> </li> </ul> </p> <section id="CD011972-sec-0046"> <h5 class="title">Trials registers</h5> <p>Two review authors (CC and YT) searched the following trials registers up to 6 August 2018: </p> <p> <ul id="CD011972-list-0006"> <li> <p>the ISRCTN registry (<a href="http://www.isrctn.com" target="_blank">www.isrctn.com</a>) using the strategy in <a href="./appendices#CD011972-sec-0145">Appendix 8</a>; </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>) using the strategy in <a href="./appendices#CD011972-sec-0145">Appendix 8</a>; </p> </li> <li> <p>the Australian New Zealand Clinical Trials Registry (ANZCTR) (<a href="http://www.anzctr.org.au" target="_blank">www.anzctr.org.au</a>) using the search term "psoriasis"; </p> </li> <li> <p>the World Health Organization International Clinical Trials Registry platform (ICTRP) (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a> ) using the strategy in <a href="./appendices#CD011972-sec-0145">Appendix 8</a>; and </p> </li> <li> <p>the EU Clinical Trials Register (<a href="http://www.clinicaltrialsregister.eu" target="_blank">www.clinicaltrialsregister.eu</a>) using the strategy in <a href="./appendices#CD011972-sec-0146">Appendix 9</a>. </p> </li> </ul> </p> </section> </section> <section id="CD011972-sec-0047"> <h4 class="title">Searching other resources</h4> <section id="CD011972-sec-0048"> <h5 class="title">References from included trials</h5> <p>We examined the reference lists of included RCTs to identify further references to relevant trials on lifestyle changes for treating psoriasis. </p> </section> <section id="CD011972-sec-0049"> <h5 class="title">Unpublished literature</h5> <p>We contacted the authors of the included RCTs to ask if they were aware of any relevant unpublished data (<a href="#CD011972-tbl-0004">Table 2</a>). </p> <div class="table" id="CD011972-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Contact with authors of included trials</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Author of included trials</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Contact date</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reply</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 November 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No reply received</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 February 2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No reply received</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not contacted because no email address was available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 November 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No reply received</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 November 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"thank you for the email and considering me and my study. I would add that reducing body weight in obese patients is helpful in increasing the response to biologics as well." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 November 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No reply received</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 November 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"Thanks for the e‐mail. We recently published a one‐year extension study of the study mentioned in your e‐mail. Other than that I do not know of any unpublished data." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 November 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No reply received</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 February 2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No reply received</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 November 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"No, I am not aware of any unpublished data on the topics."</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>We sent a standard e‐mail to all trial authors enquiring if they were aware of any unpublished data as follows: </p> <p>Dear XXX, We are conducting a Cochrane review on lifestyle changes for treating psoriasis (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011972/full" target="_blank">http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011972/full</a>), and have included your trial (XXX). As you are an expert in this field, I was wondering if you are aware of any other relevant unpublished data. Your assistance would be gratefully appreciated. Best wishes,<br/> Ching‐Chi<br/> ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐<br/> Prof Ching‐Chi Chi, MD, MMS, DPhil (Oxford)<br/> Department of Dermatology<br/> Chang Gung Memorial Hospital, Linkou<br/> 5, Fuxing St<br/> Guishan Dist<br/> Taoyuan 33305<br/> Taiwan<br/> Tel: +886‐3‐328‐1200 ext 3556<br/> E‐mail: <a href="http://mailto:chingchi@cgmh.org.tw" target="_blank"><span class="__cf_email__" data-cfemail="e2818a8b8c85818a8ba281858f8acc8d9085cc9695">[email protected]</span></a>; <a href="http://mailto:chingchichi@gmail.com" target="_blank"><span class="__cf_email__" data-cfemail="92f1fafbfcf5f1fafbf1fafbd2f5fff3fbfebcf1fdff">[email protected]</span></a><br/> ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ </p> </div> </div> </section> <section id="CD011972-sec-0050"> <h5 class="title">Adverse effects</h5> <p>We did not perform a separate search for adverse effects of the lifestyle change interventions. We only examined data on adverse events from the included RCTs. </p> </section> </section> </section> <section id="CD011972-sec-0051"> <h3 class="title" id="CD011972-sec-0051">Data collection and analysis</h3> <p>Some parts of this section uses text that was originally published in another Cochrane protocol (<a href="./references#CD011972-bbs2-0028" title="ChiCC , WangSH , PetersMC , KanjirathPP , DelamereFM , WojnarowskaF . Interventions for prevention of herpes simplex labialis (cold sores on the lips). Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD010095] ">Chi 2012</a>), and the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011972-bbs2-0048" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> <section id="CD011972-sec-0052"> <h4 class="title">Selection of studies</h4> <p>Two review authors (CC and SK) independently checked the titles and abstracts from the searches. They were not blinded to the names of the trial authors and their institutions. If we judged from the title and abstract that a trial did not relate to an RCT on lifestyle change interventions for treating psoriasis, we excluded it straight away. The same two review authors independently examined the full text of each remaining trial and judged if it met our inclusion criteria. If the two review authors disagreed on whether they should have included a trial, they achieved unanimity through discussion with a third review author (MY). We listed the trials that we excluded after examining the full text and the reasons for exclusion in the '<a href="./references#CD011972-sec-0158" title="">Characteristics of excluded studies</a>' tables. </p> </section> <section id="CD011972-sec-0053"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (CC and SK) independently extracted data (including methods, participants, interventions, outcomes, funding source, country, and setting) from the included RCTs using a data extraction form. We pilot tested the data extraction form (<a href="./appendices#CD011972-sec-0147">Appendix 10</a>). If CC and SK disagreed about the data, they consulted a third review author (MY) to achieve unanimity. One review author (CC) entered the data into Review Manager 5 (<a href="./references#CD011972-bbs2-0065" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). </p> </section> <section id="CD011972-sec-0054"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We used Cochrane's tool for assessing risk of bias in RCTs in evaluating the following domains (<a href="./references#CD011972-bbs2-0050" title="HigginsJP , AltmanDG , Sterne JA(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017</a>): </p> <p> <ul id="CD011972-list-0007"> <li> <p>Random sequence generation (selection bias): adequacy of the method of random sequence generation to produce comparable groups in every aspect except for the intervention. </p> </li> <li> <p>Allocation concealment (selection bias): adequacy of the method used to conceal the allocation sequence to prevent anyone foreseeing the allocation sequence in advance of, or during, enrolment. </p> </li> <li> <p>Blinding of participants and personnel (performance bias): adequacy of blinding participants and investigators from knowledge of which intervention a participant received. </p> </li> <li> <p>Blinding of outcome assessment (detection bias): adequacy of blinding outcome assessors from knowledge of which intervention a participant received. </p> </li> <li> <p>Incomplete outcome data (attrition bias): the completeness of outcome data for each main outcome, including attrition and exclusions from the analysis, whether attrition and exclusions were reported, the numbers in each intervention group (compared with total randomised participants), reasons for attrition or exclusions where reported, and any re‐inclusions in our analyses. </p> </li> <li> <p>Selective reporting (reporting bias). When the trial protocol was available, we examined if all pre‐specified outcomes were reported. When the trial protocol was unavailable, we examined if the published reports included all expected outcomes, including those that were prespecified. </p> </li> <li> <p>Other bias: any important concerns about bias not addressed in the other domains.</p> </li> </ul> </p> <p>Two review authors (CC and SK) independently assessed the risk of bias of included RCTs. We discussed any disagreements in our assessment with a third review author (MY) to resolve them. We judged risk of bias low, unclear or high for each individual trial. </p> </section> <section id="CD011972-sec-0055"> <h4 class="title">Measures of treatment effect</h4> <section id="CD011972-sec-0056"> <h5 class="title">Dichotomous data</h5> <p>We expressed dichotomous data as risk ratios (RR) with 95% confidence intervals (CI). When the RR was statistically significant, we also presented the number needed to treat for an additional beneficial outcome (NNTB) with 95% CI and the baseline risk to which it applies. </p> </section> <section id="CD011972-sec-0057"> <h5 class="title">Continuous data</h5> <p>We expressed continuous data as difference in means (MD) with 95% CI. If we pooled different outcome scales, we would express continuous data as standardised mean differences (SMD) with 95% CI. </p> </section> <section id="CD011972-sec-0058"> <h5 class="title">Time‐to‐event data</h5> <p>We planned to express time‐to‐event data as hazard ratios (HRs) with 95% CI.</p> </section> </section> <section id="CD011972-sec-0059"> <h4 class="title">Unit of analysis issues</h4> <p>We did not pool trials of different designs. For trials of the following types of design, we planned to analyse them separately using appropriate techniques described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011972-bbs2-0036" title="DeeksJJ , HigginsJP , Altman DG(editors) , on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>). </p> <section id="CD011972-sec-0060"> <h5 class="title">Cluster‐randomised trials</h5> <p>For cluster‐randomised trials, we planned to employ the methods described in Chapter 16.3 in the<i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011972-bbs2-0049" title="HigginsJP , DeeksJJ , Altman DG(editors) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>), and estimate the intervention effect assuming an intracluster correlation coefficient (ICC) of 0.072 (<a href="./references#CD011972-bbs2-0021" title="AdamsG , GullifordMC , UkoumunneOC , EldridgeS , ChinnS , CampbellMJ . Patterns of intra‐cluster correlation from primary care research to inform study design and analysis. Journal of Clinical Epidemiology2004;57(8):785‐94. [PUBMED: 15485730] ">Adams 2004</a>). We based this assumption on an analogy to a cluster‐RCT assessing the efficacy of adherence to the Adult Treatment Panel (ATP III) guidelines for cholesterol management (<a href="./references#CD011972-bbs2-0063" title="ParkerDR , EvangelouE , EatonCB . Intraclass correlation coefficients for cluster randomized trials in primary care: the cholesterol education and research trial (CEART). Contemporary Clinical Trials2005;26(2):260‐7. [PUBMED: 15837446] ">Parker 2005</a>). </p> </section> <section id="CD011972-sec-0061"> <h5 class="title">Cross‐over trials</h5> <p>As carry‐over effect of lifestyle changes could not be excluded in cross‐over trials, we planned to include only data from the first period for analysis. </p> </section> <section id="CD011972-sec-0062"> <h5 class="title">Trials with multiple treatment groups</h5> <p>For trials with multiple intervention groups, we would make pair‐wise comparisons of one intervention versus another. </p> </section> </section> <section id="CD011972-sec-0063"> <h4 class="title">Dealing with missing data</h4> <p>We contacted the authors of trial less than 10 years old for missing data. When missing data were not available, we planned to conduct an intention‐to‐treat (ITT) analysis to recalculate the intervention effect estimates. That is, we would include all randomised participants in the analysis and assume those with missing dichotomous outcome data were treatment failures. For missing continuous outcome data, we would adopt the last observation carried forward (LOCF) approach in analysis. When SDs for changes from baseline in continuous outcomes were missing, we followed the methods stated in section 16.1.3.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011972-bbs2-0049" title="HigginsJP , DeeksJJ , Altman DG(editors) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). When there were no adequate data for obtaining correlation coefficients, we used an imputed correlation coefficient of 0.5 (<a href="./references#CD011972-bbs2-0040" title="FollmannD , ElliotP , SuhI , CutlerJ . Variance imputation for overviews of clinical trials with continuous response. Journal of Clinical Epidemiology1992;45(7):769‐73. ">Follman 1982</a>). A sensitivity test by using imputed correlation coefficients of 0.25 and 0.75 did not show substantial variations between the three imputations. </p> </section> <section id="CD011972-sec-0064"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed the clinical diversity (i.e. variations in the participants, interventions, and outcomes) and methodological diversity (i.e. variations in the trial design and risk of bias) to determine whether a meta‐analysis was appropriate. We anticipated clinical heterogeneity would include baseline severity of psoriasis and various regimens of the same intervention. </p> <p>We calculated the I² statistic to assess statistical heterogeneity across the included trials. The <i>Cochrane Handbook for Systematic Reviews of Interventions</i> provides a rule of thumb as follows (<a href="./references#CD011972-bbs2-0036" title="DeeksJJ , HigginsJP , Altman DG(editors) , on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>): </p> <p> <ul id="CD011972-list-0008"> <li> <p>0% to 40%: might not be important;</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity;</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity; and</p> </li> <li> <p>75% to 100%: considerable heterogeneity.</p> </li> </ul> </p> </section> <section id="CD011972-sec-0065"> <h4 class="title">Assessment of reporting biases</h4> <p>When there were at least 10 trials that reported useable data on primary outcomes for an intervention, we planned to use a funnel plot to examine the publication bias. </p> </section> <section id="CD011972-sec-0066"> <h4 class="title">Data synthesis</h4> <p>We planned to provide a narrative description on all outcomes when data were available. We would only pool trials that were clinically homogeneous for participants, interventions, and outcomes. We performed a meta‐analysis employing the random‐effects model to obtain a pooled intervention effect. When a meta‐analysis was not feasible, we would summarise the data narratively instead. When relevant data were available, we would perform meta‐regression to see whether amount of weight loss reduction was associated with an outcome. </p> <p>Where we estimated results for individual trials with low numbers of outcomes (fewer than 10 in total) or where the total sample size was fewer than 30 participants and a RR was used, we would report the proportion of outcomes in each group together with a P value from a Fisher's exact test. </p> </section> <section id="CD011972-sec-0067"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to conduct the following subgroup analyses but no relevant data were available.</p> <p> <ul id="CD011972-list-0009"> <li> <p>Paediatric and adult participants</p> </li> <li> <p>Regarding lifestyle interventions that involved weight reduction, we planned to conduct a subgroup analysis on overweight and non‐overweight participants. </p> </li> </ul> </p> </section> <section id="CD011972-sec-0068"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to conduct a sensitivity analysis to examine the intervention effects after excluding trials with high risk of bias for one or more key domains. However, we did not conduct such a sensitivity analysis because only two trials (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>; <a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>), had no domains with a high risk of bias. </p> <section id="CD011972-sec-0069"> <h5 class="title">'Summary of findings' table</h5> <p>We presented two 'Summary of findings' tables in our review summarising the main outcome data for the most important comparisons (<a href="./references#CD011972-bbs2-0068" title="SchünemannHJ , OxmanAD , HigginsJP , VistGE , GlasziouP , AklE , et al. on behalf of the Cochrane GRADEing Methods Group and the Cochrane Statistical Methods Group. Chapter 11: Completing ‘Summary of findings’ tables and grading the confidence in or quality of the evidence. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Schünemann 2017</a>), and assessed the quality of the body of evidence using the five GRADE considerations (trial limitations, consistency of effect, imprecision, indirectness, and publication bias), where evidence could be rated as high, moderate, low or very low quality (<a href="./references#CD011972-bbs2-0067" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s) . Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html. ">Schünemann 2013</a>). We used the optimal information size (OIS) calculated in <a href="./appendices#CD011972-sec-0148">Appendix 11</a> as a reference for assessing imprecision. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011972-sec-0070" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011972-sec-0070"></div> <section id="CD011972-sec-0071"> <h3 class="title">Description of studies</h3> <section id="CD011972-sec-0072"> <h4 class="title">Results of the search</h4> <p>The searches of the electronic databases (see <a href="#CD011972-sec-0045">Electronic searches</a>) retrieved 1798 records. Once duplicates had been removed, we had a total of 1770 records. We excluded 1742 records based on titles and abstracts, and identified one ongoing trial (see <a href="./references#CD011972-sec-0159" title="">Characteristics of ongoing studies</a>). We obtained the full text of the remaining 27 records. We excluded nine trials (see <a href="./references#CD011972-sec-0158" title="">Characteristics of excluded studies</a>). We included 10 parallel RCTs (reported in 18 records) with 1163 participants (see <a href="./references#CD011972-sec-0157" title="">Characteristics of included studies</a>). For a further description of our screening process, see the study flow diagram <a href="#CD011972-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD011972-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD011972-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD011972-sec-0073"> <h4 class="title">Included studies</h4> <section id="CD011972-sec-0074"> <h5 class="title">Participants</h5> <p>We have presented details of the included trials in the <a href="./references#CD011972-sec-0157" title="">Characteristics of included studies</a> tables. We included 10 RCTs with 1163 participants (mean age from 43 to 61 years, 656 men and 478 women where data were available (<a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a> did not specify the number of men and women included). The type of psoriasis of included participants was chronic plaque psoriasis in eight trials (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>; <a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a>; <a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>; <a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>; <a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a>) and not specified in the <a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a> trial, while chronic plaque psoriasis, erythrodermic psoriasis, and pustular psoriasis were eligible for inclusion in <a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a>. </p> <p><a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>, <a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>, <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>, and <a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a> only included participants with moderate to severe psoriasis. <a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a> included participants with moderate to severe psoriasis who then did not achieve clearance after four weeks' systemic therapy. <a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a> only included participants with mild psoriasis. <a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a>, <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>, <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a> and <a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a> did not limit the severity of psoriasis of their included participants, but did not document the proportion with each severity. </p> <p>Only four included RCTs reported the number of participants with moderate to severe psoriasis (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>, <a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>, <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>, <a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>)<i>,</i> with 395 participants with documented moderate to severe psoriasis. Three trials (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>; <a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>), reported participants' psoriasis duration, which ranged from 13 to 20 years. The sample size ranged from 29 to 303. </p> <p>Except for <a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a>, <a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a> and <a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a>, all the participants in the other seven trials had a BMI of at least 25. The inclusion criteria regarding BMI was 25 or over but under 35 in <a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>, 25 or over in <a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a> and <a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a>, over 27 in <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>, 30 or over in <a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>, over 30 in <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>, and over 30 but under 45 in <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>. </p> </section> <section id="CD011972-sec-0075"> <h5 class="title">Design</h5> <p>All 10 trials were parallel RCTs and all trials had two arms, except <a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>, which had three. </p> <p>Trials provided treatment for between 12 weeks and three years. Participants in half of the trials were treated for 20 to 24 weeks; two trials treated participants for 12 weeks, one for 16 weeks, and another for three years. One trial did not report the treatment period (<a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a>). </p> <p>Seven trials measured outcomes at the end of treatment and there was no additional follow‐up (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>; <a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>; <a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a>; <a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a>). <a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a> treated participants for 12 weeks and measured outcomes at three, six, and nine months' follow‐up from baseline. <a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a> treated participants for 24 weeks, and measured them at this time point as well as at 36 weeks from baseline. </p> <p>Non‐profit organisations funded four trials (<a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>; <a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a>; <a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a>), one trial received funding for the education programme from pharmaceutical companies (<a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a>), and the other five trials had no funding (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>), or did not report the funding source (<a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a>; <a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>). </p> </section> <section id="CD011972-sec-0076"> <h5 class="title">Interventions and comparators</h5> <section id="CD011972-sec-0077"> <h6 class="title">Interventions</h6> <p>We included 10 trials.</p> <p> <ul id="CD011972-list-0010"> <li> <p>Six trials (499 participants, mean age from 44.3 to 61 years, 232 men and 267 women, 395 of these participants with documented moderate to severe psoriasis, where reported) examined the effects of dietary intervention, where low‐calorie diet was given, versus usual care, which included drug therapy alone; no dietary interventions; no dietetic recommendations; or instruction to continue eating ordinary, healthy foods (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>; <a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>; <a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>). Specifically, <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a> and <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a> compared the effects of combined dietary intervention and drug therapy against drug therapy alone. </p> </li> <li> <p>One trial (303 participants, median age 53 years, 215 men and 88 women, all with moderate to severe psoriasis) assessed combined dietary intervention and exercise versus information only, about the utility of reducing weight for improving the clinical control of psoriasis (<a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a>). </p> </li> <li> <p>One trial (200 participants, mean age 43.1 years, 136 men and 64 women, number of participants with moderate to severe psoriasis not reported) assessed walking exercise and continuous health education versus no interventions (<a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a>). </p> </li> <li> <p>Two trials assessed the effects of education programmes promoting healthy lifestyle in 161 participants: </p> <ul id="CD011972-list-0011"> <li> <p><a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a> (77 participants aged 18‐49 years and 55 aged 50‐78 years, mean age not reported, 73 men and 59 women; number of participants with moderate to severe psoriasis not reported) assessed the effects of general instructions on diet, smoking cessation and alcohol abstinence against usual nursing care, including psychological guidance and care, explanation and education of disease‐related knowledge, planning of activities and rest, and skin care; </p> </li> <li> <p><a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a> (29 participants, age and sex distribution of the participants not specified, with mild psoriasis (mean PASI score of 7.7 ± 3.9)) compared education programme, including healthy lifestyle and stress‐reducing techniques (involving physical training, yoga, and meditation) with medical therapy against medical therapy alone. </p> </li> </ul> </li> </ul> </p> </section> <section id="CD011972-sec-0078"> <h6 class="title">Co‐interventions</h6> <p> <ul id="CD011972-list-0012"> <li> <p><a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>: all the participants received co‐treatments with biologics including infliximab, etanercept, adalimumab, and ustekinumab with no significant differences between the dietary intervention and control groups. The trial authors did not report whether the co‐interventions could be changed. </p> </li> <li> <p><a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a>: both the intervention and control groups received medical therapy but the trial authors did not report which medications they administered. </p> </li> <li> <p><a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a>: both the experimental and control groups were encouraged to adhere to medical treatments prescribed. </p> </li> <li> <p><a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>: intramuscular methotrexate was stopped before enrolment, but trial authors did not report whether co‐interventions were allowed in the trial period. </p> </li> <li> <p><a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>: both the experimental and control groups received a fixed‐dose regimen of ciclosporin 2.5 mg per kg per day. </p> </li> <li> <p><a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>: all participants received daily therapy including one of five prescription medications: adalimumab, infliximab, etanercept, cyclosporine, or methotrexate, with no differences in the proportion of participants assuming any specific drug between two groups. The trial authors did not report whether the co‐interventions could be changed. </p> </li> <li> <p><a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>: antipsoriatic treatments, if any, had to be stable and unchanged during the trial. </p> </li> <li> <p><a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>: all the participants received concurrent NB‐UVB (narrowband ultraviolet B) phototherapy using TL‐01 lamps (310 to 312 nm) three times a week for 12 weeks. </p> </li> <li> <p><a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a>: trial authors did not state whether co‐interventions were allowed. </p> </li> <li> <p><a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a>: the dosage of weight‐adjusted therapies could be modified when there was a body weight change of more than 5 kg at a scheduled follow‐up visit. Stopping of the systemic treatment or moving to another treatment was allowed only when a participant experienced adverse events or intolerance to the prescribed treatment. The dietary intervention and control groups did not significantly differ in the proportion of participants whose co‐intervention was stopped or shifted to another (7 and 11 in the dietary intervention and control groups, respectively; P = 0.34), dose adjustment (14 and 6 in the dietary intervention and control groups, respectively; P = 0.06), and the proportion of participants who regularly applied topical drugs (12 and 16 in the dietary intervention and control groups, respectively; P = 0.44). </p> </li> </ul> </p> </section> </section> <section id="CD011972-sec-0079"> <h5 class="title">Setting</h5> <p>The settings of all included trials were hospitals. Half of the trials were conducted in Europe: four trials were conducted in Italy (<a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a>), two in China (<a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a>; <a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a>), one in Kuwait (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>), one in Belgium (<a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a>), one in Denmark (<a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>), and one in the USA (<a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>). </p> </section> <section id="CD011972-sec-0080"> <h5 class="title">Outcomes</h5> <p>The outcomes included in this systematic review that the included trials measured are listed in <a href="#CD011972-tbl-0005">Table 3</a>. </p> <div class="table" id="CD011972-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Outcomes reported by included trials</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Severity of psoriasis</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adherence to the intervention</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time to relapse</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reduction in comorbidities</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>+ outcome was reported</p> <p>‐ outcome was not reported</p> </td> </tr> </tbody> </table> </div> </section> </section> <section id="CD011972-sec-0081"> <h4 class="title">Excluded studies</h4> <p>The reasons for exclusion are listed in the <a href="./references#CD011972-sec-0158" title="">Characteristics of excluded studies</a> tables. We identified a trial from the ANZCTR (<a href="./references#CD011972-bbs2-0011" title="ACTRN12613001031752 . Exercise and nutrition intervention for patients with psoriasis [The effect of an exercise and nutrition intervention on body composition in patients with psoriasis]. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364970 (first received 12 September 2013). [ACTRN12613001031752] ">ACTRN12613001031752</a>), and contacted the trial authors for further data, but they replied to say that they had stopped the trial because very few participants were eligible. In addition, after assessing the full text, we excluded eight trials, with five excluded for not being a RCT (<a href="./references#CD011972-bbs2-0013" title="ChangYH , WangCF . Application of sweating exercise in treating psoriasis vulgaris [運動汗法在尋常型銀屑病治療中的運用]. Asia‐Pacific Traditional Medicine2016;12(4):97‐8. [DOI: 10.11954/ytctyy.201604042] ">Chang 2016</a>; <a href="./references#CD011972-bbs2-0014" title="FortesC , MastroeniS , LeffondréK . Relationship between smoking and the clinical severity of psoriasis [吸煙与銀屑病臨床嚴重度的關系]. Digest of the World Core Medical Journals ‐ Dermatology2006;2(3):28‐9. ">Fortes 2006</a>; <a href="./references#CD011972-bbs2-0016" title="HsaioCL , YenDC , HeXC , LiuSC , FangYL . Effects of various diets on the flares of psoriasis [不同飲食結構對銀屑病患者病情轉歸的影響]. Chinese Journal of Dermatology2001;34(2):132. ">Hsiao 2001</a>; <a href="./references#CD011972-bbs2-0018" title="Barisic‐DruskoV , RucevicI . Psoriasis vulgaris and low energy diet. Journal of the European Academy of Dermatology and Venereology: JEADV2003;17(Suppl 3):378. [CENTRAL: CN‐00478458] RucevicI , PerlA , Barisic‐DruskoV , Adam‐PerlM . The role of the low energy diet in psoriasis vulgaris treatment. Collegium Antropologicum2003;27(Suppl 1):41‐8. [PUBMED: 12955890] ">Rucevic 2003</a>; <a href="./references#CD011972-bbs2-0019" title="ZackheimHS , FarberEM . Rapid weight reduction and psoriasis. Archives of Dermatology1971;103(2):136‐40. [PUBMED: 4928232] ">Zackheim 1971</a>), and three excluded because they examined interventions that were not of interest for this review (<a href="./references#CD011972-bbs2-0012" title="BalatoN , MegnaM , CostanzoL , BalatoA , AyalaF . Educational and motivational support service: a pilot study for mobile‐phone‐based interventions in patients with psoriasis. British Journal of Dermatology2013; Vol. 168, issue 1:201‐5. [CENTRAL: CN‐00966396] ">Balato 2013</a>; <a href="./references#CD011972-bbs2-0015" title="HeH , DongD , JiangG . Influence of eight‐section brocade on quality of life of psoriasis patients with qiyu stagnation [八段錦對氣郁質銀屑病病人生活質量的影響]. Chinese Nursing Research2016;30(6):2251‐2. [DOI: 10.3969/j.issn.1009‐6493.2016.18.025] ">He 2016</a>; <a href="./references#CD011972-bbs2-0017" title="KeyworthC , NelsonPA , BundyC , GriffithsCE , CordingleyL . Does health message framing affect behavioural intentions in patients with psoriasis? An experimental study. British Journal of Dermatology2014;171(6):e143‐4. [CENTRAL: CN‐01088032] ">Keyworth 2014</a>). </p> <section id="CD011972-sec-0082"> <h5 class="title">Studies awaiting classification</h5> <p>We did not find any trials awaiting classification.</p> </section> <section id="CD011972-sec-0083"> <h5 class="title">Ongoing studies</h5> <p>We found one ongoing trial (<a href="./references#CD011972-bbs2-0020" title="Comparison of secukinumab 300 mg combined with a lifestyle intervention to secukinumab alone for the treatment of moderate to severe psoriasis patients with concomitant metabolic syndrome (METABOLYX). clinicaltrials.gov/ct2/show/NCT03440736 (first received 21 February 2018). ">NCT03440736</a>), which is an industry‐sponsored German multicentre trial, expected to be completed in September 2020 (see <a href="./references#CD011972-sec-0159" title="">Characteristics of ongoing studies</a>). The experimental group will receive secukinumab treatment and lifestyle intervention consisting of a structured programme to guide weight loss and increased physical activity, while the control group received secukinumab treatment alone. </p> </section> </section> </section> <section id="CD011972-sec-0084"> <h3 class="title">Risk of bias in included studies</h3> <p>The percentages of risk of bias across the included trials are presented in <a href="#CD011972-fig-0002">Figure 2</a>. The most common items that we judged at high risk of bias were blinding of participants and personnel, and incomplete outcome data. We have presented our judgement of each 'Risk of bias' item for each of the included trials in <a href="#CD011972-fig-0003">Figure 3</a> and <a href="./references#CD011972-sec-0157" title="">Characteristics of included studies</a>. </p> <div class="figure" id="CD011972-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included trials" data-id="CD011972-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included trials </p> </div> </div> </div> <div class="figure" id="CD011972-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included trial" data-id="CD011972-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included trial </p> </div> </div> </div> <section id="CD011972-sec-0085"> <h4 class="title">Allocation</h4> <p>A total of seven trials employed an adequate method of generating the randomisation sequence, such as computer‐generated randomisation, random number table, and chit pick box method, so we judged them to be at low risk of bias for this domain (<a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a>; <a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>; <a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a>; <a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a>), while the three remaining trials did not describe their methods of randomisation, so we deemed them at unclear risk (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>; <a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a>; <a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>). </p> <p>In three trials (<a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>), allocation could not be foreseen, so they were at low risk of bias. In seven other trials (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>; <a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a>; <a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>; <a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a>; <a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a>), it was unclear if allocation was concealed. </p> </section> <section id="CD011972-sec-0086"> <h4 class="title">Blinding</h4> <p>A total of five trials had a high risk of performance bias because the lack of blinding of participants might have affected subjective outcomes such as DLQI and adverse effects (<a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>; <a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>; <a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a>). Although blinding of participants was impossible due to the nature of dietary intervention in five other trials (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>; <a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a>; <a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a>), objective outcomes, for example, body weight and laboratory data, were likely not affected; hence, we considered them at unclear risk of performance bias. </p> <p>Regarding the blinding of outcome assessment, we rated seven trials at low risk of bias because the outcome assessors were blinded or the outcomes were objective (<a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a>; <a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>; <a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>; <a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a>). In three trials (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>; <a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a>; <a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a>), it was unclear whether the outcome assessors were blinded. </p> </section> <section id="CD011972-sec-0087"> <h4 class="title">Incomplete outcome data</h4> <p>We rated <a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a>, <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a> and <a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a> as high risk of bias for incomplete outcome data because of a high loss‐to‐follow‐up rate. We also rated <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a> and <a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a> as high risk of attrition bias because the dropout rates differed between the experimental and control groups. We rated six trials at low risk of attrition bias because there were no dropouts or withdrawals (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>; <a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a>; <a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>; <a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a>). </p> </section> <section id="CD011972-sec-0088"> <h4 class="title">Selective reporting</h4> <p><a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a> only reported one outcome, 'severity of psoriasis' and we rated it at high risk of selective reporting bias. All other nine trials reported all planned outcomes and we rated them at low risk of reporting bias. </p> </section> <section id="CD011972-sec-0089"> <h4 class="title">Other potential sources of bias</h4> <p>There was insufficient information to assess whether an important risk of other bias existed in the included trials. </p> </section> </section> <section id="CD011972-sec-0090"> <h3 class="title" id="CD011972-sec-0090">Effects of interventions</h3> <p>See: <a href="./full#CD011972-tbl-0001"><b>Summary of findings for the main comparison</b> Dietary intervention compared to usual care for treating psoriasis</a>; <a href="./full#CD011972-tbl-0002"><b>Summary of findings 2</b> Dietary intervention and exercise programme compared to information only for treating psoriasis</a> </p> <p>Our prespecified outcomes were as follows:</p> <p> <ul id="CD011972-list-0013"> <li> <p>Primary outcomes</p> <ul id="CD011972-list-0014"> <li> <p>Severity of psoriasis</p> </li> <li> <p>Adherence to the intervention</p> </li> </ul> </li> <li> <p>Secondary outcomes</p> <ul id="CD011972-list-0015"> <li> <p>Quality of life</p> </li> <li> <p>Time to relapse</p> </li> <li> <p>Reduction in comorbidities</p> </li> </ul> </li> </ul> </p> <p>As shown in <a href="#CD011972-tbl-0005">Table 3</a>, the included trials did not report all the review's prespecified primary and secondary outcomes. </p> <section id="CD011972-sec-0091"> <h4 class="title">Dietary intervention (strict caloric restriction) versus usual care</h4> <p>See <a href="./full#CD011972-tbl-0001">summary of findings Table for the main comparison</a>. </p> <section id="CD011972-sec-0092"> <h5 class="title">Primary outcome 1. Severity of psoriasis</h5> <p>Six included trials on dietary intervention (strict caloric restriction) reported the outcome 'severity of psoriasis' (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>; <a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>; <a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>). We merged data from the Ornish Diet and South Beach Diet groups in <a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>. </p> <p>Compared to the control group, the dietary intervention group did not have a significantly greater chance of achieving PASI 75 at week 12 (RR 1.67, 95% CI 0.59 to 4.73; 1 trial, 30 participants), but did at week 24 (RR 1.66, 95% CI 1.07 to 2.58; I² = 57%; 2 trials, 323 participants; low‐quality evidence; <a href="./references#CD011972-fig-0004" title="">Analysis 1.1</a>). The NNTB was 3 (95% CI 3 to 6). </p> <p>The dietary intervention group had a significantly greater reduction in the PASI score than the control group at week 16 (MD −2.00, 95% CI −3.94 to −0.06; 1 trial, 60 participants) and week 24 (MD −3.71, 95% CI −6.80 to −0.62; I² = 82%; 3 trials, 139 participants; very low‐quality evidence; <a href="./references#CD011972-fig-0005" title="">Analysis 1.2</a>). </p> <p>Compared to the control group, the dietary intervention group also had a significantly greater reduction in BSA at week 24 (MD −6.06, 95% CI −8.56 to −3.56; 1 trial, 262 participants; moderate‐quality evidence; <a href="./references#CD011972-fig-0006" title="">Analysis 1.3</a>). </p> </section> <section id="CD011972-sec-0093"> <h5 class="title">Primary outcome 2. Adherence to the intervention</h5> <p>As shown in <a href="./references#CD011972-fig-0007" title="">Analysis 1.4</a>, four included trials on dietary intervention provided data on the number of participants who completed the trials, which were used for calculating the outcome 'adherence to the intervention' (<a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>). We found no significant differences in adherence to the trial intervention between the dietary intervention and control groups at week 12 (RR 1.17, 95% CI 0.65 to 2.09; 1 trial, 30 participants; moderate‐quality evidence), week 16 (RR 1.04, 95% CI 0.86 to 1.25; 1 trial, 60 participants; moderate‐quality evidence), and week 24 (RR 1.26, 95% CI 0.76 to 2.09; I² = 80%; 2 trials, 60 participants; low‐quality evidence). A high statistical heterogeneity existed across the two trials that followed their participants up to 24 weeks (<a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>), but we did not carry out a subgroup analysis due to the low number of trials. In <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>, four out of 31 participants in the dietary group dropped out due to the adverse effects caused by ciclosporin, compared to 14 out of 30 in the control group, with 10 due to unsatisfactory efficacy and four due to the adverse effects of ciclosporin. <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a> lost four out of 22 participants per group to follow‐up for inadherence to drug therapy. </p> <p><a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a> reported no adverse events in any of the three groups. No other trial apart from <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a> assessed adverse events. </p> </section> <section id="CD011972-sec-0094"> <h5 class="title">Secondary outcome 1. Quality of life</h5> <p>Two trials on dietary intervention provided data on the outcome 'quality of life' (<a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>). As shown in <a href="./references#CD011972-fig-0008" title="">Analysis 1.5</a>, the dietary intervention group achieved a significantly greater reduction (improvement) in DLQI score than the control group at week 16 (MD −2.00, 95% CI −3.66 to −0.34; 1 trial, 60 participants) and month 6 (MD −12.20, 95% CI −13.92 to −10.48; 1 trial, 36 participants; moderate‐quality evidence). As shown in <a href="./references#CD011972-fig-0008" title="">Analysis 1.5</a>, only in the dietary group at month 6 did the mean reduction in DLQI score (MD −14.4 ± 1.9) achieve a minimally important difference of 5. </p> </section> <section id="CD011972-sec-0095"> <h5 class="title">Secondary outcome 2. Time to relapse</h5> <p>None of the included trials assessed this outcome.</p> </section> <section id="CD011972-sec-0096"> <h5 class="title">Secondary outcome 3. Reduction in comorbidities</h5> <section id="CD011972-sec-0097"> <h6 class="title">Reduction in obesity</h6> <p>Five included trials on dietary intervention reported the change in body weight (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>; <a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>). As shown in <a href="./references#CD011972-fig-0009" title="">Analysis 1.6</a>, the dietary intervention group achieved a significantly greater reduction in body weight than the control group at week 16 (MD −15.40, 95% CI −18.45 to −12.35; 1 trial, 60 participants) and week 24 (MD −10.04, 95% CI −15.61 to −4.48; I² = 98%; 4 trials, 401 participants; very low‐quality evidence). As to the latter comparison, the high statistical heterogeneity arose from the Kuwaiti <a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a> trial, associated with a greater reduction in body weight than the other three Italian trials (<a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>). </p> <p>Three included trials on dietary intervention assessed the change in BMI (<a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>). As illustrated in <a href="./references#CD011972-fig-0010" title="">Analysis 1.7</a>, the dietary intervention group showed a significantly greater reduction in BMI than the control group at week 16 (MD −5.00, 95% CI −5.83 to −4.17; 1 trial, 60 participants) and week 24 (MD −4.65, 95% CI −5.93 to −3.36; I² = 7%; 2 trials, 78 participants; moderate‐quality evidence). </p> <p>Four included trials on dietary intervention examined the change in waist circumference (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>). Due to zero values in the control group, we did not include <a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a> and <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a> in the meta‐analysis as the mean difference was not estimable for these two trials. As demonstrated in <a href="./references#CD011972-fig-0011" title="">Analysis 1.8</a>, the dietary intervention group obtained a significantly greater reduction in waist circumference at week 16 (MD −11.50, 95% CI −13.99 to −9.01; 1 trial, 60 participants) and week 24 (MD −12.00, 95% CI −17.27 to −6.73; 1 trial, 36 participants; low‐quality evidence). </p> </section> <section id="CD011972-sec-0098"> <h6 class="title">Reduction in blood lipids</h6> <p>As shown in <a href="./references#CD011972-fig-0012" title="">Analysis 1.9</a>, four included trials assessed the change in the serum levels of total cholesterol (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>). The dietary intervention group achieved a significantly greater reduction in total cholesterol than the control group at week 16 (MD −0.44, 95% CI −0.49 to −0.39; 1 trial, 60 participants; low‐quality evidence) and at week 24 (MD −0.55, 95% CI −1.08 to −0.01; I² = 78%; 3 trials, 359 participants; low‐quality evidence). The high statistical heterogeneity in the latter arose from the Kuwaiti <a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a> trial with a greater reduction in total cholesterol levels than the other two Italian trials (<a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>). </p> <p>The same four included trials (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>), examined the change in the serum levels of triglyceride (<a href="./references#CD011972-fig-0013" title="">Analysis 1.10</a>). Similar to the change in total cholesterol, the dietary intervention group achieved a significantly greater reduction in triglyceride than the control group at week 16 (MD −0.34, 95% CI −0.38 to −0.30; 1 trial, 60 participants; low‐quality evidence). However, there were no significant differences in the change in the serum levels of triglyceride between the two groups at week 24 (MD −0.32, 95% CI −1.09 to 0.44; I² = 82%; 3 trials, 359 participants; low‐quality evidence). The high statistical heterogeneity in the latter arose from the <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a> trial with a significant reduction in triglyceride levels, compared to no significant change in the other two trials (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>). </p> </section> </section> </section> <section id="CD011972-sec-0099"> <h4 class="title">Dietary intervention and exercise programme versus information only</h4> <p>Only one trial compared combined dietary intervention and exercise programme against only giving information about the utility of reducing weight in improving psoriasis (<a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a>). See <a href="./full#CD011972-tbl-0002">summary of findings Table 2</a>. </p> <section id="CD011972-sec-0100"> <h5 class="title">Primary outcome 1. Severity of psoriasis</h5> <p>As shown in <a href="./references#CD011972-fig-0014" title="">Analysis 2.1</a>, when compared to information only, the combination of dietary intervention and exercise programme might not have increased PASI 75 response at week 16 (RR 1.28, 95% CI 0.83 to 1.98; 1 trial, 303 participants; moderate‐quality evidence). As to two other unprespecified outcomes, combined dietary intervention and exercise programme might have increased PASI 50 response (RR 1.45, 95% CI 1.11 to 1.91; 1 trial, 303 participants; low‐quality evidence), with NNTB of 7 (95% CI 4 to 25); but did not significantly increase PASI 100 response (RR 1.57, 95% CI 0.88 to 2.83; 1 trial, 303 participants; low‐quality evidence) at week 16. </p> </section> <section id="CD011972-sec-0101"> <h5 class="title">Primary outcome 2. Adherence to the intervention</h5> <p>The number of participants who completed the trial was used for calculating adherence to the intervention. No significant differences in adherence existed between the diet and exercise group and the information only group at week 16 (RR 0.95, 95% CI 0.89 to 1.01; 1 trial, 303 participants; moderate‐quality evidence: <a href="./references#CD011972-fig-0015" title="">Analysis 2.2</a>). </p> </section> <section id="CD011972-sec-0102"> <h5 class="title">Secondary outcome 1. Quality of life</h5> <p>None of the included trials assessed this outcome.</p> </section> <section id="CD011972-sec-0103"> <h5 class="title">Secondary outcome 2. Time to relapse</h5> <p>None of the included trials assessed this outcome.</p> </section> <section id="CD011972-sec-0104"> <h5 class="title">Secondary outcome 3. Reduction in comorbidities</h5> <section id="CD011972-sec-0105"> <h6 class="title">Reduction in obesity</h6> <p>The diet and exercise group probably had a significantly greater reduction in BMI (median 3.0, interquartile range (IQR) 5.2) than the information only group (median 1.9, IQR 3.6) (P = 0.002, Mann‐Whitney U test; moderate‐quality evidence). Also, the reduction in body weight was probably greater in the diet and exercise group (median 3.0, IQR 4.5) than in the information only group (median 1.7, IQR 3.0) (P &lt; 0.001, Mann‐Whitney U test; moderate‐quality evidence). Moreover, the reduction in waist circumference was probably greater in the diet and exercise group (median 3.0, IQR 5.0) than in the information only group (median 2.0, IQR 3.5; moderate‐quality evidence). </p> </section> </section> </section> <section id="CD011972-sec-0106"> <h4 class="title">Walking exercise combined with continuous health education versus control</h4> <section id="CD011972-sec-0107"> <h5 class="title">Primary outcome 1. Severity of psoriasis</h5> <p>None of the included trials assessed this outcome.</p> </section> <section id="CD011972-sec-0108"> <h5 class="title">Primary outcome 2. Adherence to the intervention</h5> <p>None of the included trials assessed this outcome.</p> </section> <section id="CD011972-sec-0109"> <h5 class="title">Secondary outcome 1. Quality of life</h5> <p>None of the included trials assessed this outcome.</p> </section> <section id="CD011972-sec-0110"> <h5 class="title">Secondary outcome 2. Time to relapse</h5> <p>One trial (<a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a>), assessed the effect of walking exercise with continuous health education in reducing the flares of psoriasis. <a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a> did not directly report the outcome 'time to relapse', but reported the proportion of participants whose psoriasis did not recur. The intervention group was probably less likely to flare than the control group over a three‐year period (88% versus 34%; P &lt; 0.0001; moderate‐quality evidence). We downgraded our quality judgement for this trial by one level due to trial limitations, as participants were not blinded and it was unclear if outcome assessment was blinded and if allocation was concealed. </p> </section> <section id="CD011972-sec-0111"> <h5 class="title">Secondary outcome 3. Reduction in comorbidities</h5> <p>None of the included trials assessed this outcome.</p> </section> </section> <section id="CD011972-sec-0112"> <h4 class="title">Educational programme versus control (no education programme)</h4> <p>Two trials (<a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a>; <a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a>), examined the effects of an education programme promoting a healthy lifestyle. One trial (<a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a>), compared an education programme combined with medical therapy with medical therapy only. Another trial assessed the effect on psoriasis of general instructions on diet, smoking cessation and alcohol abstinence against usual nursing care (<a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a>). </p> <section id="CD011972-sec-0113"> <h5 class="title">Primary outcome 1. Severity of psoriasis</h5> <p>We are uncertain whether the intervention and control groups in <a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a> differed in the reduction in the PASI score at three, six, and nine months into the trial. At six months: MD −3.4 (95% CI −7.34 to 0.54; 1 trial, 21 participants; downgraded to very low‐quality evidence due to high risk of performance and attrition biases and imprecision; <a href="./references#CD011972-fig-0016" title="">Analysis 3.1</a>). The experimental and control groups in <a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a> may not differ in the proportion of participants achieving at least 60% reduction in BSA (RR 1.17, 95% CI 0.97 to 1.40; 1 trial, 132 participants; downgraded to low‐quality evidence due to high risk of reporting bias and imprecision; <a href="./references#CD011972-fig-0017" title="">Analysis 3.2</a>). </p> </section> <section id="CD011972-sec-0114"> <h5 class="title">Primary outcome 2. Adherence to the intervention</h5> <p>In <a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a>, the number of participants who completed the trial was used for calculating adherence to the intervention. At three months when the 12‐week education programme ended, there were six (40%) dropouts in the intervention group and one (7%) dropout in the control group (RR 0.65, 95% CI 0.42 to 1.00; P = 0.080 from Fisher's exact test; 1 trial, 29 participants; downgraded to very low‐quality evidence due to high risk of performance and attrition biases and imprecision; <a href="./references#CD011972-fig-0018" title="">Analysis 3.3</a>). </p> </section> <section id="CD011972-sec-0115"> <h5 class="title">Secondary outcome 1. Quality of life</h5> <p>The intervention and control groups in <a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a> might not have differed in the reduction in the DLQI score at three, six, and nine months into the trial (1 trial, 22 participants; downgraded to low‐quality evidence due to high risk of performance and attrition biases; <a href="./references#CD011972-fig-0019" title="">Analysis 3.4</a>). Similarly, the two groups might have not differed in the reduction in the PDI score at three, six, and nine months into the trial (1 trial, 22 participants; downgraded to low‐quality evidence due to high risk of performance and attrition biases; <a href="./references#CD011972-fig-0020" title="">Analysis 3.5</a>). The two groups might not have differed in the reduction in the Skindex 29 score, but the trial authors did not provide relevant numerical data (downgraded to low‐quality evidence due to high risk of performance and attrition biases). </p> </section> <section id="CD011972-sec-0116"> <h5 class="title">Secondary outcome 2. Time to relapse</h5> <p>None of the included trials assessed this outcome.</p> </section> <section id="CD011972-sec-0117"> <h5 class="title">Secondary outcome 3. Reduction in comorbidities</h5> <p>None of the included trials assessed this outcome.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011972-sec-0118" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011972-sec-0118"></div> <section id="CD011972-sec-0119"> <h3 class="title" id="CD011972-sec-0119">Summary of main results</h3> <p>In this systematic review we included 10 RCTs with 1163 participants. All trials except for <a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a>, <a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a> and <a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a> were limited to obese participants. </p> <p> <ul id="CD011972-list-0016"> <li> <p>Six trials (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>; <a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>; <a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>), examined the effects of dietary intervention (low‐calorie diet, with or without drug therapy) versus usual care (drug therapy alone, no dietary interventions, no dietetic recommendations, or instruction to continue eating ordinary, healthy foods). </p> </li> <li> <p>One trial (<a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a>), assessed a combined dietary intervention and exercise programme versus information only (about the utility of reducing weight for improving the clinical control of psoriasis). </p> </li> <li> <p>Another trial (<a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a>), assessed a walking exercise and continuous health education programme versus a control group receiving no intervention. </p> </li> <li> <p>Finally, two trials (<a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a>; <a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a>), included education programmes promoting healthy lifestyle versus usual care (usual nursing care including psychological guidance and care, explanation and education of disease‐related knowledge, planning of activities and rest, and skin care; <a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a>) or medical therapy alone; <a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a>). </p> </li> </ul> </p> <p>Evidence showed that when compared against usual care, dietary intervention (strict caloric restriction) may reduce the severity of psoriasis (based on a 75% or greater improvement from baseline in the PASI 75 (low‐quality evidence from two trials in 323 participants, assessment at 24 weeks)). With assessment between 24 weeks and six months, dietary intervention probably both improves quality of life (based on the DLQI score; moderate‐quality evidence from one trial in 36 participants) and reduces the BMI (moderate‐quality evidence from two trials in 78 participants). See <a href="./full#CD011972-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>Moderate‐quality evidence from one trial in 303 participants, assessed at 16 weeks, showed that when compared with information only, combined dietary intervention and exercise probably improves psoriasis severity (assessed using PASI 75), but the 95% confidence interval indicates that the combined intervention may also make little or no difference, and probably leads to a greater reduction in BMI. For this comparison, there were no data on quality of life. See <a href="./full#CD011972-tbl-0002">summary of findings Table 2</a>. </p> <p>None of the included trials measured time to relapse. We found no trials assessing interventions for alcohol abstinence or smoking cessation. The evidence reviewed is generally limited to obese people; only three trials assessed the general population. </p> <p>Adherence to the trial intervention may be greater with dietary intervention than usual care, but the 95% confidence interval indicates that dietary intervention may also make little or no difference (low‐quality evidence from two trials in 105 participants; outcome assessed between 24 weeks and six months). Adherence probably does not differ between those receiving information only or those on a combined dietary intervention and exercise programme (moderate‐quality evidence from one trial in 303 participants; outcome assessed at 16 weeks). Participants generally adhered well to the lifestyle interventions assessed in the review. </p> </section> <section id="CD011972-sec-0120"> <h3 class="title" id="CD011972-sec-0120">Overall completeness and applicability of evidence</h3> <p>We did not find enough evidence to address fully all of the objectives of the review: to assess the effects of lifestyle changes for psoriasis, including weight reduction, alcohol abstinence, smoking cessation, dietary modification, exercise, and other lifestyle change interventions. </p> <p>The available evidence (10 trials) is limited to dietary intervention with (one trial) or without (six trials) an exercise programme, walking exercise combined with continuous health education, and the effects of an education programme promoting a healthy lifestyle. There were no trials that directly compared diet intervention alone versus a combined dietary intervention and exercise programme. Only one trial (<a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>), compared the effects of two dietary interventions against no dietary intervention. There is a lack of evidence comparing the effects of different dietary interventions. Also, there is a lack of trials comparing the effects of different exercise programmes (for example, walking and jogging) in treating psoriasis. </p> <p>Only one trial evaluated the effects of walking exercise combined with continuous health education, but it did not assess any of our outcomes of interest. Just two trials examined the effects of an education programme promoting a healthy lifestyle, and they provided mainly very low‐quality evidence for the outcomes assessed, meaning we are uncertain of their results. We found no trials on a number of lifestyle changes, including alcohol abstinence, smoking cessation, coping with stress, and non‐sedentary lifestyle. </p> <p>None of the included trials assessed the outcome 'Time to relapse'. Psoriasis severity and treatment adherence were the most reported outcomes (reported by three quarters of the trials), but the quality of the evidence underlying these outcomes was mixed (very low to moderate). Thus, we could not be conclusive. Participants' BMI was the most commonly assessed comorbidity (reported in two trials), but one trial also reported change in body weight, waist circumference, and serum levels in cholesterol and triglyceride. Half of the trials assessed quality of life but evidence quality was low to moderate. </p> <p>All of the trials assessing dietary intervention with or without exercise included obese participants only, which means most of the evidence is limited to this population (only three trials included the general population). It is unclear if dietary intervention with or without an exercise programme is effective in non‐obese people with psoriasis. </p> <p>Furthermore, most trials assessing dietary interventions with or without an exercise programme only included participants with moderate to severe psoriasis (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>; <a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>; <a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a>). (The <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a> trial included participants with mild to moderate psoriasis (median PASI score 5.4; IQR 3.8 to 7.6) and showed that dietary intervention was effective in this population as well.) The severity of psoriasis was mild among participants included in <a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a>. There were no data regarding the severity of psoriasis in <a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a> and <a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a>. The available evidence is mainly applicable to chronic plaque psoriasis as most trials only included participants with this type of psoriasis. </p> <p>Except for two trials (<a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>; <a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a>), there was a lack of data post‐24 weeks; hence, we are uncertain if the benefits and harms of the interventions found will remain. </p> </section> <section id="CD011972-sec-0121"> <h3 class="title" id="CD011972-sec-0121">Quality of the evidence</h3> <p>We rated the quality of the body of evidence moderate to low for most outcomes, but there were a few results which we rated very low quality. </p> <section id="CD011972-sec-0122"> <h4 class="title">Trial limitations</h4> <p>The risk of bias of the included trials varied from low to high (<a href="#CD011972-fig-0003">Figure 3</a>). As illustrated in <a href="#CD011972-fig-0002">Figure 2</a>, a high risk of bias most frequently appeared in the 'blinding of participants and personnel' and 'incomplete outcome data'. Based on the intrinsic limitation of dietary instructions with or without an exercise programme, blinding of participants was impossible and might have affected subjective outcome assessment, for example, DLQI in four trials (<a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>; <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a>; <a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>). Loss to follow‐up exceeded 20% in <a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a>, <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a> and <a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a>. The loss to follow‐up rate differed between the experimental and control groups in <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a> and <a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a>. <a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a> reported only one outcome 'severity of psoriasis' and thus we rated it at high risk of selective reporting bias. These high risks of bias led to downgrading for many outcomes (<a href="./full#CD011972-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD011972-tbl-0002">summary of findings Table 2</a>). </p> </section> <section id="CD011972-sec-0123"> <h4 class="title">Imprecision</h4> <p>The sample size of the included trials was mostly small and the number of events was limited, but we did not downgrade for imprecision as the trials met the optimal information size. </p> </section> <section id="CD011972-sec-0124"> <h4 class="title">Inconsistency of the results</h4> <p>The direction of intervention effects was consistent across the outcomes except for the change in the levels of triglyceride. <a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a> showed a significant reduction in the levels of triglyceride in the dietary intervention group at week 16, but the data from three other trials (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>; <a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a>; <a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a>), found no significant differences in the change of triglyceride levels between the dietary intervention group and control group at week 24. We downgraded two outcomes for inconsistency (PASI 75 and adherence) in <a href="./full#CD011972-tbl-0001">summary of findings Table for the main comparison</a> because the I² statistic values were high. </p> </section> <section id="CD011972-sec-0125"> <h4 class="title">Indirectness of evidence</h4> <p>We found no indirect evidence for this review. The participants were allowed to receive concomitant systemic treatments and phototherapy, which met the clinical practice setting where patients may receive various treatments at the same time. </p> </section> <section id="CD011972-sec-0126"> <h4 class="title">Publication bias</h4> <p>No primary outcome had data from 10 trials or more. Thus, we did not use funnel plots to detect publication bias. </p> </section> </section> <section id="CD011972-sec-0127"> <h3 class="title" id="CD011972-sec-0127">Potential biases in the review process</h3> <p>We conducted this review following the a priori protocol (<a href="./references#CD011972-bbs2-0079" title="ChiCC , KoSH , YehML , WangSH , TsaiYS , HsuMY . Lifestyle changes for treating psoriasis. Cochrane Database of Systematic Reviews2015, Issue 11. [DOI: 10.1002/14651858.CD011972] ">Chi 2015b</a>). As shown in <a href="#CD011972-sec-0045">Electronic searches</a>, we conducted a systematic search of databases including Chinese and a Taiwanese databases. We also scanned the references of included trials and enquired if the trial authors were aware of any relevant unpublished data. We did not impose any limitation on language or publication status. Therefore, our search is unlikely to have missed relevant important trials. Although we made some departures from the protocol (see <a href="#CD011972-sec-0155">Differences between protocol and review</a>), these changes are unlikely to introduce biases. We did not make a posteriori decisions about the analysis or investigation of heterogeneity after obtaining the data. </p> <p><a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a> only reported one outcome. However, the authors did not provide a correspondence email address and thus we were unable to contact them for further unreported data. As shown in <a href="#CD011972-tbl-0004">Table 2</a>, we contacted other trial authors but only a few of them replied. If the trial authors had provided unreported data and imprecision was thus mitigated, we could have upgraded the quality of the body of evidence. </p> </section> <section id="CD011972-sec-0128"> <h3 class="title" id="CD011972-sec-0128">Agreements and disagreements with other studies or reviews</h3> <p>We have only found two other reviews on a similar topic for this review (<a href="./references#CD011972-bbs2-0075" title="UpalaS , SanguankeoA . Effect of lifestyle weight loss intervention on disease severity in patients with psoriasis: a systematic review and meta‐analysis. International Journal of Obesity (2005)2015;39(8):1197‐202. [PUBMED: 25920774] ">Upala 2015</a>; <a href="./references#CD011972-bbs2-0041" title="FordAR , SiegelM , BagelJ , CordoroKM , GargA , GottliebA , et al. Dietary recommendations for adults with psoriasis or psoriatic arthritis from the medical board of the National Psoriasis Foundation: a systematic review. JAMA dermatology2018;154(8):934‐50. [PUBMED: 29926091] ">Ford 2018</a>). One systematic review assessed the effect of weight loss intervention on the severity of psoriasis (<a href="./references#CD011972-bbs2-0075" title="UpalaS , SanguankeoA . Effect of lifestyle weight loss intervention on disease severity in patients with psoriasis: a systematic review and meta‐analysis. International Journal of Obesity (2005)2015;39(8):1197‐202. [PUBMED: 25920774] ">Upala 2015</a>). The conclusion agrees with our review, indicating that weight loss interventions are effective in reducing the severity of psoriasis in obese people. However, the review included a trial on people with psoriatic arthritis (<a href="./references#CD011972-bbs2-0037" title="DiMinnoMN , PelusoR , IervolinoS , RussolilloA , LupoliR , ScarpaR . Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor alpha blockers. Annals of the Rheumatic Diseases2014;73(6):1157‐62. [PUBMED: 23771989] ">Di Minno 2014</a>), and did not separate combined diet intervention and exercise programme (<a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a>) from the meta‐analysis. The other systematic review aimed to provide dietary recommendations for adults with psoriasis or psoriatic arthritis, or both, from the Medical Board of the US National Psoriasis Foundation (<a href="./references#CD011972-bbs2-0041" title="FordAR , SiegelM , BagelJ , CordoroKM , GargA , GottliebA , et al. Dietary recommendations for adults with psoriasis or psoriatic arthritis from the medical board of the National Psoriasis Foundation: a systematic review. JAMA dermatology2018;154(8):934‐50. [PUBMED: 29926091] ">Ford 2018</a>). They strongly recommend dietary weight reduction with a hypocaloric diet in overweight and obese people with psoriasis, which is consistent with our conclusions. </p> <p>The clinical benefits of dietary intervention with or without an exercise programme is compatible with the theory that weight reduction and exercise improve body composition and reduce the amounts of adipose tissue that potentiates inflammation (<a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a>). The lack of consistent evidence in the reduction in triglycerides associated with dietary intervention suggests that hypertriglyceridaemia in people with psoriasis may be associated with factors other than inflammation, for example, congenital defect in lipid metabolism. A genetic trial has found that people with psoriasis frequently had common genetic variants predisposing to hyperlipidaemia (<a href="./references#CD011972-bbs2-0054" title="LuY , ChenH , NikamoP , Qi LowH , HelmsC , SeielstadM , et al. Association of cardiovascular and metabolic disease genes with psoriasis. Journal of Investigative Dermatology2013; Vol. 133, issue 3:836‐9. [PUBMED: 23190900] ">Lu 2013</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011972-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD011972-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/full#CD011972-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011972-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included trials" data-id="CD011972-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included trials </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/full#CD011972-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011972-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included trial" data-id="CD011972-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included trial </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/full#CD011972-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011972-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dietary intervention versus usual care, Outcome 1 PASI 75." data-id="CD011972-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Dietary intervention versus usual care, Outcome 1 PASI 75.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011972-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dietary intervention versus usual care, Outcome 2 Change in PASI." data-id="CD011972-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Dietary intervention versus usual care, Outcome 2 Change in PASI.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011972-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dietary intervention versus usual care, Outcome 3 Change in BSA." data-id="CD011972-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Dietary intervention versus usual care, Outcome 3 Change in BSA.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011972-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dietary intervention versus usual care, Outcome 4 Adherence to the intervention." data-id="CD011972-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Dietary intervention versus usual care, Outcome 4 Adherence to the intervention.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011972-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dietary intervention versus usual care, Outcome 5 Change in DLQI." data-id="CD011972-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Dietary intervention versus usual care, Outcome 5 Change in DLQI.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011972-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dietary intervention versus usual care, Outcome 6 Change in body weight." data-id="CD011972-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Dietary intervention versus usual care, Outcome 6 Change in body weight.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011972-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dietary intervention versus usual care, Outcome 7 Change in BMI." data-id="CD011972-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Dietary intervention versus usual care, Outcome 7 Change in BMI.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011972-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dietary intervention versus usual care, Outcome 8 Change in waist circumference." data-id="CD011972-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Dietary intervention versus usual care, Outcome 8 Change in waist circumference.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011972-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dietary intervention versus usual care, Outcome 9 Change in total cholesterol." data-id="CD011972-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Dietary intervention versus usual care, Outcome 9 Change in total cholesterol.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011972-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dietary intervention versus usual care, Outcome 10 Change in triglyceride." data-id="CD011972-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Dietary intervention versus usual care, Outcome 10 Change in triglyceride.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011972-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Dietary intervention and exercise programme versus information only, Outcome 1 PASI response." data-id="CD011972-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Dietary intervention and exercise programme versus information only, Outcome 1 PASI response. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011972-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Dietary intervention and exercise programme versus information only, Outcome 2 Adherence to the intervention." data-id="CD011972-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Dietary intervention and exercise programme versus information only, Outcome 2 Adherence to the intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011972-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Education programme versus control, Outcome 1 Reduction in PASI." data-id="CD011972-fig-0016" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Education programme versus control, Outcome 1 Reduction in PASI.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011972-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Education programme versus control, Outcome 2 At least 60% reduction in BSA." data-id="CD011972-fig-0017" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Education programme versus control, Outcome 2 At least 60% reduction in BSA. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011972-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Education programme versus control, Outcome 3 Adherence to the intervention." data-id="CD011972-fig-0018" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Education programme versus control, Outcome 3 Adherence to the intervention.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011972-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Education programme versus control, Outcome 4 Reduction in DLQI." data-id="CD011972-fig-0019" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Education programme versus control, Outcome 4 Reduction in DLQI.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011972-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/urn:x-wiley:14651858:media:CD011972:CD011972-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_t/tCD011972-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Education programme versus control, Outcome 5 Reduction in PDI." data-id="CD011972-fig-0020" src="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Education programme versus control, Outcome 5 Reduction in PDI.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/media/CDSR/CD011972/image_n/nCD011972-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011972-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Dietary intervention compared to usual care for treating psoriasis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dietary intervention compared to usual care for treating psoriasis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with psoriasis<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> dietary intervention<br/> <b>Comparison:</b> usual care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with usual care</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with dietary intervention</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Severity of psoriasis</b> </p> <p>PASI 75 (the proportion of participants achieving at least 75% improvement from baseline in the Psoriasis Area and Severity Index)<br/> Follow‐up: 24 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Trial population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.66<br/> (1.07 to 2.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>323<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>537 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>891 per 1000<br/> (575 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adherence to the intervention</b><br/> Follow‐up: 24 weeks to 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Trial population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.26<br/> (0.76 to 2.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>105<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>654 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>824 per 1000<br/> (497 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> <p>Change in DLQI (scale from 0 to 30; lower DLQI scores represent improvement in quality of life) </p> <p>Follow‐up: 6 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life assessed by change in DLQI was −2.2</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 12.20 lower<br/> (13.92 lower to 10.48 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to relapse</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in comorbidities</b> </p> <p>Change in BMI (lower BMI is beneficial)<br/> Follow‐up: 24 weeks to 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in comorbidities assessed by change in BMI was 0.1 kg/m²</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 4.65 kg/m² lower<br/> (5.93 lower to 3.36 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BMI:</b> body‐mass index; <b>CI:</b> confidence interval; <b>DLQI:</b> Dermatology Life Quality Index; <b>MD:</b> mean difference; <b>PASI:</b> Psoriasis Area and Severity Index; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by two levels due to a high risk of attrition bias or performance bias, and inconsistency.<br/> <sup>b</sup>Downgraded by one level due to a high risk of performance bias. </p> <p>None of the outcomes reported here were downgraded for imprecision as the optimal information size was met (<a href="./appendices#CD011972-sec-0148">Appendix 11</a>). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Dietary intervention compared to usual care for treating psoriasis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/full#CD011972-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011972-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Dietary intervention and exercise programme compared to information only for treating psoriasis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dietary intervention and exercise programme compared to information only for treating psoriasis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with psoriasis<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> dietary intervention and exercise programme<br/> <b>Comparison:</b> information only </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with information only</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with dietary intervention and exercise programme</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Severity of psoriasis</b> </p> <p>PASI 75 (the proportion of participants achieving at least 75% improvement from baseline in the Psoriasis Area and Severity Index)<br/> Follow‐up: 16 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Trial population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.28<br/> (0.83 to 1.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>303<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>191 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>244 per 1000<br/> (158 to 378) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adherence to the intervention</b><br/> Follow‐up: 16 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Trial population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.95<br/> (0.89 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>303<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>954 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>906 per 1000<br/> (849 to 963) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to relapse</b> </p> <p>Not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in comorbidities</b> </p> <p>Change in BMI (lower BMI is beneficial)<br/> Follow‐up: 16 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Median change in BMI was 1.9 kg/m²</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Median 1.10 kg/m² lower</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>303<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The diet and exercise group had a significantly greater reduction in BMI (median 3.0, IQR 5.2) than the information only group (median 1.9, IQR 3.6; P = 0.002, Mann‐Whitney U test) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BMI:</b> body‐mass index; <b>CI:</b> confidence interval; <b>IQR:</b> interquartile range; <b>PASI:</b> Psoriasis Area and Severity Index; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by one level due to a high risk of attrition bias. </p> <p>None of the outcomes reported here were downgraded for imprecision as the optimal information size was met (<a href="./appendices#CD011972-sec-0148">Appendix 11</a>). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Dietary intervention and exercise programme compared to information only for treating psoriasis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/full#CD011972-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011972-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Potential mechanism of lifestyle change interventions in treating psoriasis</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Lifestyle change intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Potential mechanism in treating psoriasis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weight reduction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reduction of the amounts of adipose tissue that causes inflammation</p> <p>Decrease in the volume of drug distribution</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Alcohol abstinence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reduction of inflammation associated with alcohol consumption</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Smoking cessation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reduction of the production of free radicals induced by smoking</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement of the body composition</p> <p>Reduction of inflammation</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Potential mechanism of lifestyle change interventions in treating psoriasis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/full#CD011972-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011972-tbl-0004"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Contact with authors of included trials</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Author of included trials</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Contact date</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reply</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 November 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No reply received</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 February 2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No reply received</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not contacted because no email address was available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 November 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No reply received</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 November 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"thank you for the email and considering me and my study. I would add that reducing body weight in obese patients is helpful in increasing the response to biologics as well." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 November 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No reply received</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 November 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"Thanks for the e‐mail. We recently published a one‐year extension study of the study mentioned in your e‐mail. Other than that I do not know of any unpublished data." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 November 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No reply received</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 February 2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No reply received</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 November 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"No, I am not aware of any unpublished data on the topics."</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>We sent a standard e‐mail to all trial authors enquiring if they were aware of any unpublished data as follows: </p> <p>Dear XXX, We are conducting a Cochrane review on lifestyle changes for treating psoriasis (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011972/full" target="_blank">http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011972/full</a>), and have included your trial (XXX). As you are an expert in this field, I was wondering if you are aware of any other relevant unpublished data. Your assistance would be gratefully appreciated. Best wishes,<br/> Ching‐Chi<br/> ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐<br/> Prof Ching‐Chi Chi, MD, MMS, DPhil (Oxford)<br/> Department of Dermatology<br/> Chang Gung Memorial Hospital, Linkou<br/> 5, Fuxing St<br/> Guishan Dist<br/> Taoyuan 33305<br/> Taiwan<br/> Tel: +886‐3‐328‐1200 ext 3556<br/> E‐mail: <a href="http://mailto:chingchi@cgmh.org.tw" target="_blank"><span class="__cf_email__" data-cfemail="aecdc6c7c0c9cdc6c7eecdc9c3c680c1dcc980dad9">[email protected]</span></a>; <a href="http://mailto:chingchichi@gmail.com" target="_blank"><span class="__cf_email__" data-cfemail="d3b0bbbabdb4b0bbbab0bbba93b4beb2babffdb0bcbe">[email protected]</span></a><br/> ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Contact with authors of included trials</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/full#CD011972-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011972-tbl-0005"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Outcomes reported by included trials</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Severity of psoriasis</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adherence to the intervention</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time to relapse</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reduction in comorbidities</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0001" title="Al‐MutairiN , ManchandaY . The effect of weight reduction on treatment outcomes in obese patients of psoriasis on biologic therapy. Journal of the American Academy of Dermatology2015;72(5 Suppl 1):AB254. Al‐MutairiN , NourT . The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy2014;14(6):749‐56. [CENTRAL: CN‐00993130; PUBMED: 24661040] ">Al‐Mutairi 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0002" title="BostoenJ , BrackeS , DeKeyserS , LambertJ . An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology2012;167(5):1025‐31. [CENTRAL: CN‐00856431; PUBMED: 22709422] BostoenJ , GeusensB , LambertJ , BrackeS , DekeyserS . An educational program for patients with psoriasis and atopic dermatitis: a prospective randomized, controlled trial. British Journal of Dermatology2012; Vol. 66, issue 4 Suppl 1:Ab84. [CENTRAL: CN‐01005670] ">Bostoen 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0003" title="ChenGL . Sensible diet and nursing strategy for psoriasis [銀屑病的合理飲食和護理對策]. Laboratory Medicine and Clinic2013;10(16):2186‐7. ">Chen 2013a</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0004" title="DelGiglioM , GisondiP , TessariG , GirolomoniG . Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator‐blinded study. Dermatology2012;224(1):31‐7. [CENTRAL: CN‐01017641; PUBMED: 22456343] ">Del Giglio 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0005" title="GisondiP , DelGiglioM , DiFrancescoV , ZamboniM , GirolomoniG . Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: a randomized, controlled, investigator‐blinded clinical trial. American Journal of Clinical Nutrition2008;88(5):1242‐7. [CENTRAL: CN‐00665491] ">Gisondi 2008</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0006" title="GuidaB , NapoleoneA , TrioR , NastasiA , BalatoN , LaccettiR , et al. Energy‐restricted, n‐3 polyunsaturated fatty acids‐rich diet improves the clinical response to immuno‐modulating drugs in obese patients with plaque‐type psoriasis: a randomized control clinical trial. Clinical Nutrition (Edinburgh, Scotland)2014;33(3):399‐405. [CENTRAL: CN‐00988461] ">Guida 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0007" title="GeikerN , JensenP , ZachariaeC , ChristensenR , SchaadtB , StenderS , et al. Weight loss improves the cardiovascular risk profile of obese patients with psoriasis. Obesity Reviews2014;15(S2):175. [CENTRAL: CN‐01066070] JensenP . Erratum: Effect of weight loss on the severity of psoriasis: a randomized clinical study (JAMA Dermatology (2013) 149:7 (795‐801) doi:10.1001/ jamadermatol.2013.722). JAMA Dermatology2013;149(8):997. [PUBMED: 23752669] JensenP , ChristensenR , ZachariaeC , GeikerNR , SchaadtBK , StenderS , et al. Long‐term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow‐up study. American Journal of Clinical Nutrition2016;104(2):259‐65. [PUBMED: 27334236] JensenP , ZachariaeC , ChristensenR , GeikerN , SchaadtB , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomised controlled trial. Journal of Investigative Dermatology2013;133(Supp 1):S182. [EMBASE: 71083543] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis. Acta Dermato‐Venereologica2014;94(6):691‐4. [CENTRAL: CN‐01022975] JensenP , ZachariaeC , ChristensenR , GeikerNR , SchaadtBK , StenderS , et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology2013;149(7):795‐801. [PUBMED: 23752669] LarssonLK , GeikerNR , JensenP , ZachariaeC , AstrupA , SkovL . Weight loss and skin manifestations in obese patients with psoriasis ‐ a controlled randomized cross‐over study. Obesity Reviews2011;12(S1):205. [EMBASE: 70605096] ">Jensen 2013</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0008" title="KimballAB , AlavianC , Alora‐PalliM , BagelJ . Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy. Journal of the European Academy of Dermatology and Venereology : JEADV2012;26(12):1582‐4. [CENTRAL: CN‐00899892] ">Kimball 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0009" title="LiYF , JiangLJ , TaoY , QinGL , LiZ , HeW . The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence [慢走運動與持續健康教育對預防銀屑病復發的效果研究]. Journal of Nursing Adminstration2015;15(4):294‐6. ">Li 2015</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011972-bbs2-0010" title="NaldiL , ContiA , CazzanigaS , PatriziA , PazzagliaM , LanzoniA , et al. Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology2014;170(3):634‐42. [CENTRAL: CN‐00981223] ">Naldi 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>+ outcome was reported</p> <p>‐ outcome was not reported</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Outcomes reported by included trials</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/full#CD011972-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011972-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Dietary intervention versus usual care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 PASI 75 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Week 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [0.59, 4.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Week 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>323</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.66 [1.07, 2.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Change in PASI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Week 16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐3.94, ‐0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Week 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.71 [‐6.80, ‐0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Change in BSA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.06 [‐8.56, ‐3.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Adherence to the intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Week 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.65, 2.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Week 16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.86, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Week 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.76, 2.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Change in DLQI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Week 16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.0 [‐3.66, ‐0.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 month 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐12.2 [‐13.92, ‐10.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Change in body weight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Week 16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.4 [‐18.45, ‐12.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Week 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.04 [‐15.61, ‐4.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Change in BMI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Week 16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.0 [‐5.83, ‐4.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Week 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.65 [‐5.93, ‐3.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Change in waist circumference <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Week 16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.5 [‐13.99, ‐9.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Month 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐12.0 [‐17.27, ‐6.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Change in total cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Week 16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.44 [‐0.49, ‐0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Week 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.55 [‐1.08, ‐0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Change in triglyceride <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Week 16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.34 [‐0.38, ‐0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Week 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐1.09, 0.44]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Dietary intervention versus usual care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011972-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Dietary intervention and exercise programme versus information only</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 PASI response <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 PASI 75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.83, 1.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 PASI 50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [1.11, 1.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 PASI 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [0.88, 2.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Adherence to the intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.89, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Dietary intervention and exercise programme versus information only</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011972-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Education programme versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Reduction in PASI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 9 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 At least 60% reduction in BSA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.97, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adherence to the intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.42, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Reduction in DLQI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 9 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Reduction in PDI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 9 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Education programme versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011972.pub2/references#CD011972-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011972.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011972-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011972-note-0007">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011972-note-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011972-note-0006">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD011972-note-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD011972-note-0004">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011972-note-0002">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD011972-note-0003">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011972\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011972\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011972\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011972\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011972\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011972\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011972\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011972\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011972\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011972\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011972\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011972\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011972\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011972\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011972\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011972\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011972\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011972\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=dLyXbLct&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011972.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011972.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011972.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011972.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011972.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718729148"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011972.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718729152"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011972.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dd76e6e38f47a',t:'MTc0MDcxODcyOS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 